Case number 1:19-cv-01727
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 18, 2023 | 489 | NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 488 Notice of Appeal (Federal Circuit), filed by Allergan USA, Inc., Eden Biodesign, LLC, Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International, Ltd., and Janssen Pharmaceuticals NV. USCA Case Number 2024-1061. (nms) (Entered: 10/18/2023) (4) |
| Oct 12, 2023 | 488 | Notice of Appeal* (1) |
| Oct 12, 2023 | 486 | FINAL JUDGMENT (CASE CLOSED). Signed by Judge Richard G. Andrews on 10/12/2023. (nms) (Entered: 10/12/2023) (4) |
| Oct 12, 2023 | 487 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,691,860; 9,115,091; 9,364,489; 9,675,587; 9,789,125; 10,188,632. (Attachments: # 1 Final Judgment)(nms) (Entered: 10/12/2023) (0) |
| Oct 11, 2023 | 485 | PROPOSED Final Judgment, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/11/2023 (nms). (Entered: 10/11/2023) (4) |
| Oct 2, 2023 | 484 | STIPULATION and Order extending deadline to submit proposed final judgment to October 11, 2023, by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) Modified on 10/3/2023 (nms). (Entered: 10/02/2023) (2) |
| Sep 27, 2023 | 483 | TRIAL OPINION: For the foregoing reasons, I find the asserted claims of the '627, '291, ' 179,'792, and '516 patents invalid for lack of written description. I find the asserted claim of the '356 patent to be invalid for obviousness-type double patenting. The parties shall submit a final judgment consistent with this memorandum opinion within one week. Signed by Judge Richard G. Andrews on 9/27/2023. (nms) (Entered: 09/27/2023) (43) |
| Sep 6, 2023 | 482 | Joint Status Report on the Impact of In Re Cellect on Claim 40 of the '356 Patent, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits A-B)(Tigan, Jeremy) Modified on 9/7/2023 (nms). (Entered: 09/06/2023) (0) |
| Aug 29, 2023 | 481 | ORAL ORDER: The Court of Appeals decided In re Cellect, No. 22-1293, on August 28, 2023. The parties are requested to submit a joint status report by September 6, 2023, on the impact of that decision on how the Court should resolve asserted claim 40 of the 356 patent. Ordered by Judge Richard G. Andrews on 8/29/2023. (lah) (Entered: 08/29/2023) (0) |
| Aug 4, 2023 | 480 | MEMORANDUM ORDER: Defendants motion to strike Dr. Berkland's testimony at trial (D.I. 463 ) is GRANTED-IN-PART and DENIED-IN-PART. Dr. Berkland's testimony at Tr. 383:1-6; 412:22-413:6; 428:25-429:3; 429:8-20 is struck from the record (see Memorandum Order for further details). Signed by Judge Richard G. Andrews on 8/4/2023. (nms) (Entered: 08/04/2023) (5) |
| Aug 2, 2023 | 479 | NOTICE requesting Clerk to remove Daniel B. O'Boyle as co-counsel.. (Tigan, Jeremy) (Entered: 08/02/2023) (3) |
| May 24, 2023 | 478 | RESPONSE to 477 Notice of Supplemental Authority, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 5/24/2023 (nms). (Entered: 05/24/2023) (4) |
| May 22, 2023 | 477 | NOTICE of of Supplemental Authority by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A)(Weinblatt, Richard) (Entered: 05/22/2023) (Main Document) (3) |
| May 22, 2023 | 477 | NOTICE of of Supplemental Authority by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A)(Weinblatt, Richard) (Entered: 05/22/2023) (Exhibit A) (24) |
| Mar 16, 2023 | 472 | Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding hyperlinked post-trial documents. (Gattuso, Dominick) Modified on 3/16/2023 (nms). (Entered: 03/16/2023) (1) |
| Mar 16, 2023 | 473 | MOTION for Leave to File a Surreply Brief in Response to Defendants' Reply Post-Trial Brief - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) Modified on 3/16/2023 (nms). (Entered: 03/16/2023) (Main Document) (4) |
| Mar 16, 2023 | 474 | Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding Motion for Leave to File Sur-Reply Brief (D.I. 473 ). (Gattuso, Dominick) Modified on 3/16/2023 (nms). (Entered: 03/16/2023) (2) |
| Mar 16, 2023 | 475 | Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding electronic versions of Plaintiffs' post-trial briefs with hyperlinks. (Tigan, Jeremy) Modified on 3/16/2023 (nms). (Entered: 03/16/2023) (1) |
| Mar 16, 2023 | 476 | ORAL ORDER: The Motion for Leave to file a Surreply Brief (D.I. 473 ) is DENIED. Ordered by Judge Richard G. Andrews on 3/16/2023. (nms) (Entered: 03/16/2023) (0) |
| Mar 16, 2023 | 473 | MOTION for Leave to File a Surreply Brief in Response to Defendants' Reply Post-Trial Brief - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) Modified on 3/16/2023 (nms). (Entered: 03/16/2023) (Exhibit A) (6) |
| Mar 9, 2023 | 470 | REPLY BRIEF re 463 MOTION to Strike Dr. Berkland's Trial Testimony Not Previously Disclosed filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) (Entered: 03/09/2023) (8) |
| Mar 9, 2023 | 471 | POST-TRIAL Reply Brief, by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) Modified on 3/9/2023 (nms). (Entered: 03/09/2023) (20) |
| Feb 3, 2023 | 467 | ANSWERING BRIEF in Opposition re 463 MOTION to Strike Dr. Berkland's Trial Testimony Not Previously Disclosed filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.Reply Brief due date per Local Rules is 2/10/2023. (Attachments: # 1 Exhibits A-C)(Tigan, Jeremy) (Entered: 02/03/2023) (Main Document) (7) |
| Feb 3, 2023 | 468 | POST-Trial Answering Brief, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 2/3/2023 (nms). (Entered: 02/03/2023) (30) |
| Feb 3, 2023 | 469 | Proposed Findings of Fact by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) (Entered: 02/03/2023) (30) |
| Feb 3, 2023 | 467 | ANSWERING BRIEF in Opposition re 463 MOTION to Strike Dr. Berkland's Trial Testimony Not Previously Disclosed filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.Reply Brief due date per Local Rules is 2/10/2023. (Attachments: # 1 Exhibits A-C)(Tigan, Jeremy) (Entered: 02/03/2023) (Exhibits A-C) (30) |
| Jan 19, 2023 | 466 | Official Transcript of Pretrial Conference held on 10/21/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/9/2023. Redacted Transcript Deadline set for 2/21/2023. Release of Transcript Restriction set for 4/19/2023. (Triozzi, Heather) (Entered: 01/19/2023) (24) |
| Dec 30, 2022 | 465 | SO ORDERED Granting 464 STIPULATION and Order to Extend Time (*Reset Briefing Schedule: re 463 MOTION to Strike Dr. Berkland's Trial Testimony Not Previously Disclosed. Answering Brief due 2/3/2023, Reply Brief due 3/9/2023). Signed by Judge Richard G. Andrews on 12/30/2022. (nms) (Entered: 12/30/2022) (2) |
| Dec 23, 2022 | 464 | STIPULATION and Order to Extend Time - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 12/23/2022 (nms). (Entered: 12/23/2022) (2) |
| Dec 22, 2022 | 461 | Proposed Findings of Fact by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) (Entered: 12/22/2022) (30) |
| Dec 22, 2022 | 462 | POST-Trial Opening Brief, by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) Modified on 12/22/2022 (nms). (Entered: 12/22/2022) (30) |
| Dec 22, 2022 | 463 | MOTION to Strike Dr. Berkland's Trial Testimony Not Previously Disclosed - filed by Sun Pharmaceutical Industries Limited. (Attachments: # 1 Proposed Order)(Gattuso, Dominick) Modified on 12/22/2022 (nms). (Entered: 12/22/2022) (Main Document) (2) |
| Dec 22, 2022 | 463 | MOTION to Strike Dr. Berkland's Trial Testimony Not Previously Disclosed - filed by Sun Pharmaceutical Industries Limited. (Attachments: # 1 Proposed Order)(Gattuso, Dominick) Modified on 12/22/2022 (nms). (Entered: 12/22/2022) (Text of Proposed Order) (2) |
| Dec 21, 2022 | 460 | STIPULATION and Order to file proposed findings of fact and post-trial opening and answering briefs to December 22, 2022 and February 3, 2023 - filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) Modified on 12/21/2022 (nms). (Entered: 12/21/2022) (2) |
| Dec 14, 2022 | 457 | Official Transcript of Bench Trial held on 11/7/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/4/2023. Redacted Transcript Deadline set for 1/17/2023. Release of Transcript Restriction set for 3/14/2023. (Triozzi, Heather) (Entered: 12/14/2022) (269) |
| Dec 14, 2022 | 458 | Official Transcript of Bench Trial held on 11/8/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/4/2023. Redacted Transcript Deadline set for 1/17/2023. Release of Transcript Restriction set for 3/14/2023. (Triozzi, Heather) (Entered: 12/14/2022) (260) |
| Dec 14, 2022 | 459 | Official Transcript of Bench Trial held on 11/9/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/4/2023. Redacted Transcript Deadline set for 1/17/2023. Release of Transcript Restriction set for 3/14/2023. (Triozzi, Heather) (Entered: 12/14/2022) (47) |
| Dec 13, 2022 | 456 | NOTICE of Lodging of Plaintiffs' Trial Demonstratives by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC (Attachments: # 1 Exhibits 1-4)(Tigan, Jeremy) (Entered: 12/13/2022) (Main Document) (4) |
| Dec 13, 2022 | 456 | NOTICE of Lodging of Plaintiffs' Trial Demonstratives by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC (Attachments: # 1 Exhibits 1-4)(Tigan, Jeremy) (Entered: 12/13/2022) (Exhibits 1-4) (30) |
| Dec 7, 2022 | 455 | NOTICE of Lodging of Defendants' Trial Demonstratives by Sun Pharmaceutical Industries Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Gattuso, Dominick) (Entered: 12/07/2022) (Main Document) (2) |
| Dec 7, 2022 | 455 | NOTICE of Lodging of Defendants' Trial Demonstratives by Sun Pharmaceutical Industries Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Gattuso, Dominick) (Entered: 12/07/2022) (Exhibit 1) (30) |
| Dec 7, 2022 | 455 | NOTICE of Lodging of Defendants' Trial Demonstratives by Sun Pharmaceutical Industries Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Gattuso, Dominick) (Entered: 12/07/2022) (Exhibit 2) (28) |
| Dec 7, 2022 | 455 | NOTICE of Lodging of Defendants' Trial Demonstratives by Sun Pharmaceutical Industries Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Gattuso, Dominick) (Entered: 12/07/2022) (Exhibit 3) (30) |
| Dec 7, 2022 | 455 | NOTICE of Lodging of Defendants' Trial Demonstratives by Sun Pharmaceutical Industries Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Gattuso, Dominick) (Entered: 12/07/2022) (Exhibit 4) (5) |
| Dec 7, 2022 | 455 | NOTICE of Lodging of Defendants' Trial Demonstratives by Sun Pharmaceutical Industries Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Gattuso, Dominick) (Entered: 12/07/2022) (Exhibit 5) (11) |
| Dec 7, 2022 | 455 | NOTICE of Lodging of Defendants' Trial Demonstratives by Sun Pharmaceutical Industries Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Gattuso, Dominick) (Entered: 12/07/2022) (Exhibit 6) (15) |
| Nov 22, 2022 | 454 | STIPULATION to Extend Time to submit trial transcript errata to November 30, 2022 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 11/23/2022 (nms). (Entered: 11/22/2022) (2) |
| Nov 21, 2022 | 453 | Exhibit and Witness List for Bench Trial held 11/7/2022 - 11/9/2022. (lah) (Entered: 11/21/2022) (6) |
| Nov 17, 2022 | 451 | STIPULATION of Dismissal as to all claims and counterclaims between relating to United States Patent Nos. 11,007,179; 11,160,792; 10,188,632; 11,311,516; and 9,675,587, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (2) |
| Nov 17, 2022 | 452 | SO ORDERED Granting 451 Stipulation and Proposed Order dismissing all claims and counterclaims between Plaintiff and "MSN" relating to United States Patent Nos. 11,007,179; 11,160,792; 10,188,632; 11,311,516; and 9,675,587. Signed by Judge Richard G. Andrews on 11/17/2022. (nms) (Entered: 11/17/2022) (2) |
| Nov 16, 2022 | 447 | SO ORDERED Granting 446 Stipulation and Order Regarding Post-Trial Briefing. Signed by Judge Richard G. Andrews on 11/16/2022. (nms) (Entered: 11/16/2022) (3) |
| Nov 16, 2022 | 448 | REDACTED VERSION of 412 MOTION in Limine No. 1 by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-3)(Tigan, Jeremy) (Entered: 11/16/2022) (Main Document) (9) |
| Nov 16, 2022 | 449 | REDACTED VERSION of 413 Defendants Motion in Limine No. 1 by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-9)(Tigan, Jeremy) (Entered: 11/16/2022) (Main Document) (10) |
| Nov 16, 2022 | 450 | REDACTED VERSION of 414 Proposed Pretrial Order, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-16)(Tigan, Jeremy) (Entered: 11/16/2022) (Main Document) (27) |
| Nov 16, 2022 | 450 | REDACTED VERSION of 414 Proposed Pretrial Order, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-16)(Tigan, Jeremy) (Entered: 11/16/2022) (Exhibits 1-16) (30) |
| Nov 16, 2022 | 448 | REDACTED VERSION of 412 MOTION in Limine No. 1 by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-3)(Tigan, Jeremy) (Entered: 11/16/2022) (Exhibits 1-3) (30) |
| Nov 16, 2022 | 449 | REDACTED VERSION of 413 Defendants Motion in Limine No. 1 by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-9)(Tigan, Jeremy) (Entered: 11/16/2022) (Exhibits 1-9) (30) |
| Nov 15, 2022 | 445 | REDACTED VERSION of 428 Answering Brief in Opposition, by Sun Pharmaceutical Industries Limited. (Attachments: # 1 Exhibits A-F)(Gattuso, Dominick) Modified on 11/16/2022 (nms). (Entered: 11/15/2022) (Main Document) (23) |
| Nov 15, 2022 | 446 | STIPULATION and Order Regarding Post-Trial Briefing by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) (Entered: 11/15/2022) (3) |
| Nov 15, 2022 | 445 | REDACTED VERSION of 428 Answering Brief in Opposition, by Sun Pharmaceutical Industries Limited. (Attachments: # 1 Exhibits A-F)(Gattuso, Dominick) Modified on 11/16/2022 (nms). (Entered: 11/15/2022) (Exhibit A-F (Public)) (30) |
| Nov 14, 2022 | 444 | MEMORANDUM OPINION regarding Motion for Judgment Pursuant to FED. R. CIV. P. 12(c) (D.I. 423 ). Signed by Judge Richard G. Andrews on 11/14/2022. (nms) (Entered: 11/14/2022) (14) |
| Nov 7, 2022 | 442 | STIPULATION and Order regarding Dismissal of claims and counterclaims between Plaintiffs and Sun relating to United States Patent No. 9,675,587 and United States Patent No. 10,188,632, by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) Modified on 11/7/2022 (nms). (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 443 | SO ORDERED Granting 442 Stipulation and Order regarding Dismissal of claims and counterclaims between Plaintiffs and Sun relating to United States Patent No. 9,675,587 and United States Patent No. 10,188,632. Signed by Judge Richard G. Andrews on 11/7/2022. (nms) (Entered: 11/07/2022) (2) |
| Nov 6, 2022 | 439 | MOTION for Pro Hac Vice Appearance of Attorney Amy Jing Ying Zhao - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) (Entered: 11/06/2022) (5) |
| Nov 6, 2022 | 440 | Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding response to questions concerning Sun's late-disclosed patent misuse defense. (Tigan, Jeremy) Modified on 11/6/2022 (nms). (Entered: 11/06/2022) (3) |
| Nov 6, 2022 | 441 | Letter to The Honorable Richard G. Andrew, from Dominick T. Gattuso, Esq., regarding Patent Misuse. (Gattuso, Dominick) Modified on 11/6/2022 (nms). (Entered: 11/06/2022) (3) |
| Nov 5, 2022 | 437 | Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding scope of trial. (Tigan, Jeremy) Modified on 11/5/2022 (nms). (Entered: 11/05/2022) (3) |
| Nov 5, 2022 | 438 | Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding response to letter (D.I. 437 ) and upcoming trial. (Gattuso, Dominick) Modified on 11/5/2022 (nms). (Entered: 11/05/2022) (2) |
| Nov 4, 2022 | 436 | STIPULATION and Order to Extend Time to file redacted document to November 15, 2022 - filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) Modified on 11/7/2022 (nms). (Entered: 11/04/2022) (2) |
| Nov 3, 2022 | 431 | STIPULATION Concerning Representative Asserted Claims (between Plaintiffs and Sun Pharmaceutical Industries Limited), by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 11/3/2022 (nms). (Entered: 11/03/2022) (3) |
| Nov 3, 2022 | 432 | STIPULATION Concerning Representative Asserted Claims (between Plaintiffs and MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.), by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 11/3/2022 (nms). (Entered: 11/03/2022) (2) |
| Nov 3, 2022 | 433 | SO ORDERED Granting 431 Stipulation Concerning Representative Asserted Claims (between Plaintiffs and Sun Pharmaceutical Industries Limited). Signed by Judge Richard G. Andrews on 11/3/2022. (nms) (Entered: 11/03/2022) (3) |
| Nov 3, 2022 | 434 | SO ORDERED Granting 432 Stipulation Concerning Representative Asserted Claims (between Plaintiffs and MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.). Signed by Judge Richard G. Andrews on 11/3/2022. (nms) (Entered: 11/03/2022) (2) |
| Nov 3, 2022 | 435 | ORAL ORDER: Plaintiffs motion for judgment on the pleadings (D.I. 423 ) is GRANTED in part and DENIED in part. The motion is granted with respect to the unclean hands counterclaim and defense. The motion is denied with respect to prosecution history estoppel, judicial estoppel, and patent misuse. Judgment for Plaintiff and against Defendant Sun will be entered on Counterclaim Count IV to the extent it alleges unclean hands, and the Fourth Defense is struck. An opinion will follow in due course. Ordered by Judge Richard G. Andrews on 11/3/2022. (nms) (Entered: 11/03/2022) (0) |
| Nov 1, 2022 | 430 | STIPULATION TO EXTEND TIME for the parties to submit redacted versions of the Proposed Joint Pretrial Order and Motions in Limine to November 16, 2022 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) (Entered: 11/01/2022) (2) |
| Oct 31, 2022 | 429 | STIPULATION and Proposed Order to extend time to submit redacted versions of the Proposed Joint Pretrial Order and Motions in Limine to November 1, 2022 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/31/2022 (nms). (Entered: 10/31/2022) (2) |
| Oct 28, 2022 | 427 | STIPULATION and Proposed Order to Extend Time to submit redacted versions to October 31, 2022 - filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) Modified on 10/28/2022 (nms). (Entered: 10/28/2022) (2) |
| Oct 28, 2022 | 428 | [SEALED] ANSWERING BRIEF in Opposition re 423 MOTION for Judgment Pursuant to FED. R. CIV. P. 12(c) filed by Sun Pharmaceutical Industries Limited.Reply Brief due date per Local Rules is 11/4/2022. (Attachments: # 1 Exhibit A-F, # 2 Certificate of Service)(Gattuso, Dominick) (Entered: 10/28/2022) (0) |
| Oct 27, 2022 | 426 | SO ORDERED Granting 424 Proposed Joint Pretrial Order. Signed by Judge Richard G. Andrews on 10/27/2022. (nms) (Entered: 10/27/2022) (24) |
| Oct 26, 2022 | 425 | STIPULATION and Proposed Order to submit redacted versions of the Proposed Joint Pretrial Order and Motions in Limine to October 28, 2022 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/26/2022 (nms). (Entered: 10/26/2022) (2) |
| Oct 25, 2022 | 422 | ANSWER to 349 Amended Answer to Complaint, Counterclaim - by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) (Entered: 10/25/2022) (16) |
| Oct 25, 2022 | 423 | MOTION for Judgment Pursuant to FED. R. CIV. P. 12(c) - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/25/2022 (nms). (Entered: 10/25/2022) (4) |
| Oct 25, 2022 | 424 | Proposed Pretrial Order, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/26/2022 (nms). (Entered: 10/25/2022) (24) |
| Oct 20, 2022 | 418 | MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 10/20/2022. (nms) (Entered: 10/20/2022) (7) |
| Oct 20, 2022 | 419 | ORDER: Defendants' motion for leave to amend its answer (D.I. 374 ) is DENIED. Signed by Judge Richard G. Andrews on 10/20/2022. (nms) (Entered: 10/20/2022) (1) |
| Oct 20, 2022 | 420 | MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 10/20/2022. (nms) (Entered: 10/20/2022) (10) |
| Oct 20, 2022 | 421 | ORDER: Plaintiffs motion to dismiss Sun's counterclaim, of unclean hands (Counterclaim IV) (D.I. 354 ) is DENIED. Plaintiffs' motion to strike Sun's defenses of unclean hands (Fourth Defense), prosecution history estoppel and/or judicial estoppel (Fifth Defense), and patent misuse (Seventh Defense) (D.I. 354 ) is DENIED. Plaintiffs' motion to strike Sun's defense of waiver, estoppel, and laches (Sixth Defense) (D.I. 354 ) is GRANTED. Signed by Judge Richard G. Andrews on 10/20/2022. (nms) (Entered: 10/20/2022) (1) |
| Oct 19, 2022 | 415 | STIPULATION TO EXTEND TIME time for the parties to submit redacted versions of the Proposed Joint Pretrial Order and Motions in Limine to October 26, 2022 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) (Entered: 10/19/2022) (2) |
| Oct 19, 2022 | 416 | ORAL ORDER: Plaintiffs motion in limine (D.I. 412 ) is GRANTED. Paragraphs 175, 195, 203, 209, and 217 of the Gemeinhart Report (see D.I. 412-1, Ex. 1) are STRUCK. Gemeinhart is a pharmaceutical expert. His opinions on unconscionability are legal conclusions beyond his area of expertise and would not be helpful to the trier of fact. Ordered by Judge Richard G. Andrews on 10/19/2022. (nms) Modified on 10/19/2022 (nms). (Entered: 10/19/2022) (0) |
| Oct 19, 2022 | 417 | ORAL ORDER: Defendants motion in limine (D.I. 413 ) is GRANTED in part and DISMISSED without prejudice to renew in part. Defendants development work from 2017-2019 is irrelevant to the issue of written description as of the priority date in 2013. Thus, testimony about the development work offered for that purpose is excluded. Whether Defendants development work is relevant to enablement as of 2013 is less clear. For one thing, Defendants go first on invalidity, and what they may say about enablement is unknown to me. For a second thing, the brief excerpt from Plaintiffs experts invalidity report (D.I. 413-1, Ex. 4, 337) is unclear how relevant the proposed testimony would be, given that it involves events that occurred about five years after the 2013 priority date, appears to involve an at-best superficial analysis, and may or may not be responsive to the actual enablement analysis Defendants will put forth. Thus, the motion in limine as to enablement is dismissed without prejudice to renew. Ordered by Judge Richard G. Andrews on 10/19/2022. (nms) (Entered: 10/19/2022) (0) |
| Oct 11, 2022 | 412 | [SEALED] MOTION in Limine No. 1 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-3)(Tigan, Jeremy) Modified on 10/11/2022 (nms). (Entered: 10/11/2022) (0) |
| Oct 11, 2022 | 413 | [SEALED] Defendants Motion in Limine No. 1 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-9)(Tigan, Jeremy) Modified on 10/11/2022 (nms). (Entered: 10/11/2022) (0) |
| Oct 11, 2022 | 414 | [SEALED] Joint Proposed Pretrial Order, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC, Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Attachments: # 1 Exhibits 1-16)(Tigan, Jeremy) Modified on 10/11/2022 (nms). (Entered: 10/11/2022) (0) |
| Oct 10, 2022 | 411 | NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. § 282 filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) (Entered: 10/10/2022) (2) |
| Oct 4, 2022 | 408 | STIPULATION Concerning Infringement of U.S. Patent Nos. 11,090,291 and 11,229,627, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/4/2022 (nms). (Entered: 10/04/2022) (3) |
| Oct 4, 2022 | 409 | SO ORDERED re 407 Stipulation Concerning Infringement of U.S. Patent Nos. 11,007,179, 11,090,291, 11,160, 792, and 11,311,516. Signed by Judge Richard G. Andrews on 10/4/2022. (nms) (Main Document 409 replaced on 10/4/2022) (nms). (Entered: 10/04/2022) (3) |
| Oct 4, 2022 | 410 | SO ORDERED Granting 408 Stipulation Concerning Infringement of U.S. Patent Nos. 11,090,291 and 11,229,627. Signed by Judge Richard G. Andrews on 10/4/2022. (nms) (nms). (Entered: 10/04/2022) (3) |
| Oct 3, 2022 | 407 | STIPULATION Concerning Infringement of U.S. Patent Nos. 11,007,179, 11,090,291, 11,160,792, and 11,311,516, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/4/2022 (nms). (Entered: 10/03/2022) (3) |
| Sep 27, 2022 | 406 | MOTION for Pro Hac Vice Appearance of Attorney Annie R. Steiner of Winston & Strawn LLP on behalf of Defendant Sun Pharmaceutical Industries Ltd - filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) (Entered: 09/27/2022) (4) |
| Sep 22, 2022 | 404 | SO ORDERED Granting 402 Stipulation and Proposed Order regarding narrowing of issues at trial. Signed by Judge Richard G. Andrews on 9/22/2022. (nms) (Entered: 09/22/2022) (2) |
| Sep 22, 2022 | 405 | SO ORDERED Granting 403 Stipulation and Proposed Order regarding narrowing of issues regarding Protective Order use. Signed by Judge Richard G. Andrews on 9/22/2022. (nms) (Entered: 09/22/2022) (2) |
| Sep 21, 2022 | 402 | STIPULATION and [Proposed] Order Regarding Evidence and Arguments at Trial, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 9/22/2022 (nms). (Entered: 09/21/2022) (2) |
| Sep 21, 2022 | 403 | STIPULATION and [Proposed] Order Regarding the Protective Order, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 9/22/2022 (nms). (Entered: 09/21/2022) (2) |
| Aug 24, 2022 | 398 | NOTICE to Take Deposition of Maureen Donovan, Ph.D. on August 29, 2022 filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) (Entered: 08/24/2022) (4) |
| Aug 24, 2022 | 399 | NOTICE to Take Deposition of Richard Gemeinhart, Ph.D. on August 31, 2022 filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) (Entered: 08/24/2022) (4) |
| Aug 24, 2022 | 400 | NOTICE to Take Deposition of Raj Suryanarayanan, Ph.D. on September 1, 2022 filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) (Entered: 08/24/2022) (4) |
| Aug 24, 2022 | 401 | NOTICE to Take Deposition of Colin W. Howden, M.D. on September 2, 2022 filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) (Entered: 08/24/2022) (4) |
| Aug 17, 2022 | 397 | Official Transcript of Virtual Conference held on 8/3/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/7/2022. Redacted Transcript Deadline set for 9/19/2022. Release of Transcript Restriction set for 11/15/2022. (Triozzi, Heather) (Entered: 08/17/2022) (5) |
| Aug 9, 2022 | 395 | REPLY BRIEF re 374 MOTION for Leave to File Amended Answer, Affirmative Defenses, and Counterclaims to Amended Complaint filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Weinblatt, Richard) (Entered: 08/09/2022) (6) |
| Aug 9, 2022 | 396 | REDACTED VERSION of 388 Answering Brief in Opposition, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits A-F)(Tigan, Jeremy) Modified on 8/10/2022 (nms). (Entered: 08/09/2022) (Main Document) (20) |
| Aug 9, 2022 | 396 | REDACTED VERSION of 388 Answering Brief in Opposition, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits A-F)(Tigan, Jeremy) Modified on 8/10/2022 (nms). (Entered: 08/09/2022) (Exs. A-F) (18) |
| Aug 8, 2022 | 392 | ORAL ORDER: The Court has read the letters concerning a partial summary judgment motion by MSN. (D.I. 376 , 384 , 391 ). Plaintiffs DOE theory for the 179 and 792 patents appears to be that lactose is the equivalent of silicified microcrystalline cellulose and that croscamellose sodium is the equivalent of crospovidone. Defendant wants to brief whether this theory is barred by prosecution history estoppel. MSNs argument is based on the prosecution history of the parent. I am not persuaded by MSNs letter that there is a strong likelihood that I would be able to grant MSN summary judgment on the two patents in question. I also note the inefficiency, as I believe the two patents are also asserted against co-defendant Sun (D.I. 375 at 2 (validity challenge)), so I am going to hear about them at trial regardless. MSNs request (D.I. 376 ) is DENIED. Ordered by Judge Richard G. Andrews on 8/8/2022. (nms) (Entered: 08/08/2022) (0) |
| Aug 8, 2022 | 393 | REDACTED VERSION of 384 Letter, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-6)(Tigan, Jeremy) Modified on 8/8/2022 (nms). (Entered: 08/08/2022) (Main Document) (4) |
| Aug 8, 2022 | 394 | NOTICE to Take Deposition of Cory Berkland, Ph.D. on August 11, 2022, beginning at 9:00 a.m. EST. (remote) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) (Entered: 08/08/2022) (2) |
| Aug 8, 2022 | 393 | REDACTED VERSION of 384 Letter, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # 1 Exhibits 1-6)(Tigan, Jeremy) Modified on 8/8/2022 (nms). (Entered: 08/08/2022) (Exs. 1-6) (30) |
| Aug 4, 2022 | 391 | Letter (4) Docket Text: Letter to The Honorable Richard G. Andrews from Richard C. Weinblatt regarding Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Reply in Support of Its Request for Leave to File a Motion for Summary Judgment - re [376] Letter. (Weinblatt, Richard) |
| Aug 3, 2022 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Conference held on 8/3/2022. Local counsel present for Plaintiff: J. Tigan. Local counsel present for Defendant MSN; R. Weinblatt. Local counsel present for Sun; D. Gattuso. The request for a three day trial was confirmed by the Court. (Court Reporter Heather Triozzi.) (nms) |
| Aug 3, 2022 | 389 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding the Reply Expert Report of Maureen D. Donovan, Ph.D., Regarding Noninfringement of U.S. Patent Nos. 9,675,587 and 10,188,632 by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Aug 3, 2022 | 390 | Order (2) Docket Text: SO ORDERED Granting [389] Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 8/3/2022. (nms) |
| Aug 2, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Defendant Suns request for leave to file a summary judgment motion re: DOE of the colloidal silica limitation (D.I. [366]) is DENIED. Ordered by Judge Richard G. Andrews on 8/2/2022. (nms) |
| Aug 1, 2022 | 381 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Reply Expert Declaration of Cory Berkland, Ph.D. Regarding Infringement of Asserted Patents by MSN filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Aug 1, 2022 | 382 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Reply Expert Declaration of Cory Berkland, Ph.D. Regarding Infringement of Asserted Patents by Sun filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Aug 1, 2022 | 383 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Colin W. Howden, M.D. filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Aug 1, 2022 | 385 | Letter (1) Docket Text: Joint Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding length of trial. (Tigan, Jeremy) Modified on 8/2/2022 (nms). |
| Aug 1, 2022 | 386 | Main Document (6) Docket Text: REDACTED VERSION of [376] Letter by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A)(Weinblatt, Richard) |
| Aug 1, 2022 | 386 | Exhibit A (47) |
| Jul 29, 2022 | 378 | Main Document (5) Docket Text: REDACTED VERSION of [373] Letter, by Allergan Holdings Unlimited Company, Allergan USA, Inc.. (Attachments: # (1) Exhibits 1-6)(Tigan, Jeremy) Modified on 7/29/2022 (nms) |
| Jul 29, 2022 | 378 | Exs. 1-6 (50) |
| Jul 29, 2022 | 379 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Richard A. Gemeinhart, Ph.D., Regarding Invalidity and Unenforceability of U.S. Patent Nos. 9,675,587, 10,188,632, 11,007,179, 11,090,291, 111,160,792, 11,229,627 and 11,311,516 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Weinblatt, Richard) |
| Jul 29, 2022 | 380 | Main Document (8) Docket Text: REDACTED VERSION of [374] MOTION for Leave to File Amended Answer, Affirmative Defenses, and Counterclaims to Amended Complaint by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Text of Proposed Order)(Weinblatt, Richard) |
| Jul 29, 2022 | 380 | Exhibit A (30) |
| Jul 29, 2022 | 380 | Exhibit B (30) |
| Jul 29, 2022 | 380 | Exhibit C (4) |
| Jul 29, 2022 | 380 | Text of Proposed Order (1) |
| Jul 25, 2022 | 377 | Main Document (3) Docket Text: REDACTED VERSION of [375] Letter, by Sun Pharmaceutical Industries Limited. (Attachments: # (1) Exhibit A, # (2) Certificate of Service)(Gattuso, Dominick) |
| Jul 25, 2022 | 377 | Exhibit A (3) |
| Jul 25, 2022 | 377 | Certificate of Service (1) |
| Jul 22, 2022 | N/A | Set Answering Brief Deadline (0) Docket Text: Set Answering Brief Deadline re [374] MOTION for Leave to File Amended Answer, Affirmative Defenses, and Counterclaims to Amended Complaint. Answering Brief/Response due date per Local Rules is 8/5/2022. (nms) |
| Jul 22, 2022 | 374 | Main Document (8) Docket Text: MOTION for Leave to File Amended Answer, Affirmative Defenses, and Counterclaims to Amended Complaint - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Proposed Order)(Weinblatt, Richard) Modified on 7/24/2022 (nms). |
| Jul 22, 2022 | 374 | Exhibit A (30) |
| Jul 22, 2022 | 374 | Exhibit B (30) |
| Jul 22, 2022 | 374 | Exhibit C (4) |
| Jul 22, 2022 | 374 | Text of Proposed Order (1) |
| Jul 20, 2022 | 372 | Main Document (4) Docket Text: REDACTED VERSION of [366] Letter, by Sun Pharmaceutical Industries Limited. (Attachments: # (1) Exhibit A-B, # (2) Certificate of Service)(Gattuso, Dominick) |
| Jul 20, 2022 | 372 | Exhibit A-B (19) |
| Jul 20, 2022 | 372 | Certificate of Service (1) |
| Jul 18, 2022 | 369 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Maureen D. Donovan, Ph.D., Regarding Noninfringement of U.S. Patent Nos. 9,675,587 and 10,188,632 (with Exhibits 1-2) [CONFIDENTIAL] filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jul 18, 2022 | 370 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Responsive Expert Report of Cory Berkland, Ph.D., regarding the Validity of the Asserted Patents (MSN Defendants) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jul 18, 2022 | 371 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Responsive Expert Report of Cory Berkland, Ph.D., regarding the Validity of the Asserted Patents (Sun Pharmaceutical Industries Limited) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jul 15, 2022 | 368 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rebuttal Expert Report of Dr. Raj Suryanarayanan filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Weinblatt, Richard) |
| Jul 14, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A conference to discuss trial length is now set for 8/3/2022, at 3:00 PM. The conference will be held virtually using TEAMS. A joint email with the email addresses for all those participating in the conference is due to the Case Manager by 4:00 PM on 7/27/2022. Further, the Court requests that the parties submit a letter 24 hours before the conference explaining why four days (28 hours) are necessary for trial. Ordered by Judge Richard G. Andrews on 7/14/2022. (nms) |
| Jul 12, 2022 | 365 | Order (2) Docket Text: SO ORDERED Granting Stipulation and Proposed Order to Consolidate and Extend Time (see Stipulation for further details). Signed by Judge Richard G. Andrews on 7/12/2022. Associated Cases: 1:20-cv-01479-RGA, 1:19-cv-01727-RGA(nms) |
| Jul 5, 2022 | 364 | Letter (1) Docket Text: Joint Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding the length and format of trial. (Tigan, Jeremy) Modified on 7/6/2022 (nms). |
| Jul 1, 2022 | 361 | Main Document (25) Docket Text: REDACTED VERSION of [358] Answering Brief in Opposition, by Sun Pharmaceutical Industries Limited. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Jul 1, 2022 | 361 | Certificate of Service (1) |
| Jul 1, 2022 | 362 | Main Document (4) Docket Text: REDACTED VERSION of [359] Declaration by Sun Pharmaceutical Industries Limited. (Attachments: # (1) Exhibit A-V, # (2) Certificate of Service)(Gattuso, Dominick) |
| Jul 1, 2022 | 362 | Exhibit A-V (182) |
| Jul 1, 2022 | 362 | Certificate of Service (1) |
| Jul 1, 2022 | 363 | Reply Brief (15) Docket Text: REPLY BRIEF re [354] MOTION to Dismiss Counterclaims and to Strike Affirmative Defenses MOTION to Strike [349] Amended Answer to Complaint, Counterclaim filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Jun 30, 2022 | 360 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Expert Declaration of Cory Berkland, Ph.D. Regarding Infringement of Asserted Patents by MSN and (2) Expert Declaration of Susan J. Bogdanowich-Knipp, Ph.D. Regarding Analysis of MSN's ANDA Products filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jun 17, 2022 | 357 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Richard A. Gemeinhart, Ph.D., Regarding Invalidity and Unenforceability of U.S. Patent Nos. 9,675,587, 10,188,632, 11,007,179, 11,090,291, 111,160,792, 11,229,627 and 11,311,516 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Weinblatt, Richard) |
| Jun 10, 2022 | 354 | Motion to Dismiss for Failure to State a Claim (4) Docket Text: MOTION to Dismiss Counterclaims and to Strike Affirmative Defenses - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 6/13/2022 (nms). |
| Jun 10, 2022 | 355 | Opening Brief in Support (16) Docket Text: OPENING BRIEF in Support re [354] MOTION to Dismiss Counterclaims and to Strike Affirmative Defenses, filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.Answering Brief/Response due date per Local Rules is 6/24/2022. (Tigan, Jeremy) Modified on 6/13/2022 (nms). |
| Jun 10, 2022 | 356 | Main Document (3) Docket Text: DECLARATION of Carolyn S. Wall re [354] MOTION to Dismiss Counterclaims and to Strike Affirmative Defenses, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Exhibits A-B)(Tigan, Jeremy) Modified on 6/13/2022 (nms). |
| Jun 10, 2022 | 356 | Exhibits A-B (5) |
| Jun 2, 2022 | 352 | Stipulation (3) Docket Text: STIPULATION Regarding U.S. Patent Nos. 8,691,860, 9,115,091, 9,364,489, 9,789,125 and 7,741,356 by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Jun 2, 2022 | 353 | Order (3) Docket Text: SO ORDERED Granting [352] Stipulation and Proposed Order regarding certifications to the FDA and withdrawal of claims of infringement.Signed by Judge Richard G. Andrews on 6/2/2022. (nms) |
| May 31, 2022 | 351 | Answer to Counterclaim (17) Docket Text: ANSWER to [345] Answer to Amended Complaint and Counterclaims, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) Modified on 6/1/2022 (nms). |
| May 27, 2022 | 349 | Amended Answer to Complaint (19) Docket Text: AMENDED ANSWER to [343] Amended Complaint, Affirmative Defenses and COUNTERCLAIMS against All Plaintiffs, by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) Modified on 5/31/2022 (nms). |
| May 27, 2022 | 350 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Final Invalidity and Unenforceability Contentions Regarding U.S. Patent Nos. 11,229,627 and 11,311,516 filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| May 20, 2022 | 347 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Claim Charts for Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. Relating Each Accused Product to the Asserted Claims filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| May 20, 2022 | 348 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Claim Charts for Defendant Sun Pharmaceutical Industries Limited, Relating Each Accused Product to the Asserted Claim filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| May 16, 2022 | 345 | Answer to Amended Complaint (19) Docket Text: ANSWER to [341] Amended Complaint, and COUNTERCLAIMS against Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC, by MSN Pharmaceuticals, Inc., MSN Laboratories Private Limited.(Weinblatt, Richard) Modified on 5/16/2022 (nms). |
| May 16, 2022 | 346 | Answer to Amended Complaint (15) Docket Text: ANSWER to [343] Amended Complaint, and COUNTERCLAIM against All Plaintiffs, by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) Modified on 5/16/2022 (nms). |
| Apr 28, 2022 | 341 | Main Document (9) Docket Text: FIRST Amended Complaint against MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. - filed by Eden Biodesign, LLC, Allergan USA, Inc., Allergan Holdings Unlimited Company. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Tigan, Jeremy) Modified on 4/28/2022 (nms). |
| Apr 28, 2022 | 341 | Exhibit A (24) |
| Apr 28, 2022 | 341 | Exhibit B (25) |
| Apr 28, 2022 | 342 | Patent/Trademark Report to Commissioner (1) Docket Text: Amended Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,229,627 B1 ;11,311,516 B2. (Tigan, Jeremy) Modified on 4/28/2022 (nms). |
| Apr 28, 2022 | 343 | Main Document (9) Docket Text: FIRST Amended Complaint against Sun Pharmaceutical Industries Limited - filed by Eden Biodesign, LLC, Allergan USA, Inc., Allergan Holdings Unlimited Company. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Tigan, Jeremy) Modified on 4/28/2022 (nms). |
| Apr 28, 2022 | 343 | Exhibit A (24) |
| Apr 28, 2022 | 343 | Exhibit B (25) |
| Apr 28, 2022 | 344 | Patent/Trademark Report to Commissioner (1) Docket Text: Amended Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,229,627 B1 ;11,311,516 B2. (Tigan, Jeremy) Modified on 4/28/2022 (nms). |
| Apr 28, 2022 | 343 | Amended Complaint* (1) |
| Apr 28, 2022 | 341 | Amended Complaint* (1) |
| Apr 18, 2022 | 339 | Stipulation (3) Docket Text: STIPULATION Regarding Filing and Service of Amended Complaints and Answers Thereto by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Apr 18, 2022 | 340 | Order (3) Docket Text: SO ORDERED Granting [339] Stipulation and Proposed Order regarding amended pleadings deadline, service and answer deadline. Signed by Judge Richard G. Andrews on 4/18/2022. (nms) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel) |
| Mar 22, 2022 | 338 | Order (4) Docket Text: SO ORDERED Granting Stipulation and Proposed Order to Consolidate Cases and Modify Scheduling Order (D.I. 7 in 22-cv-182-RGA; D.I. 337 in 19-cv-1727-RGA; D.I. 7 in 22-cv-181-RGA). Signed by Judge Richard G. Andrews on 3/22/2022. Associated Cases: 1:19-cv-01727-RGA, 1:22-cv-00181-RGA, 1:22-cv-00182-RGA(nms) |
| Mar 21, 2022 | 337 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order to Consolidate Cases and Modify Scheduling Order by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Mar 15, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [336] Stipulation and Order to Modify Scheduling Order. Signed by Judge Richard G. Andrews on 3/15/2022. (nms) |
| Mar 15, 2022 | 336 | Stipulation (3) Docket Text: STIPULATION to Modify Scheduling Order by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) |
| Feb 24, 2022 | 334 | Main Document (4) Docket Text: AMENDED Stipulation of Dismissal by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Letter)(Tigan, Jeremy) Modified on 2/24/2022 (nms). |
| Feb 24, 2022 | 334 | Letter to The Honorable Richard G. Andrews (1) |
| Feb 24, 2022 | 335 | Order (4) Docket Text: SO ORDERED Granting [334] Amended Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 2/24/2022. (nms) |
| Feb 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [333] Stipulation and Proposed Order to Modify Scheduling Order. Signed by Judge Richard G. Andrews on 2/22/2022. (nms) |
| Feb 22, 2022 | 333 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Modify Scheduling Order by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Feb 18, 2022 | 331 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-7) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Feb 18, 2022 | 332 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-7) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Feb 9, 2022 | 327 | Stipulation of Dismissal (4) Docket Text: STIPULATION of Dismissal between Plaintiffs and Zydus Pharmaceuticals (USA) Inc., by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 2/10/2022 (nms). |
| Feb 9, 2022 | 328 | Order (4) Docket Text: SO ORDERED Granting [327] Stipulation and Proposed Order of Dismissal between Plaintiffs and Zydus Pharmaceuticals (USA) Inc.. Signed by Judge Richard G. Andrews on 2/9/2022. (nms) |
| Feb 9, 2022 | 329 | Stipulation of Dismissal (4) Docket Text: STIPULATION of Dismissal between Plaintiffs and Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc., by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 2/9/2022 (nms). |
| Feb 9, 2022 | 330 | Order (4) Docket Text: SO ORDERED Granting [329] Stipulation of Dismissal between Plaintiffs and Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.. Signed by Judge Richard G. Andrews on 2/9/2022. (nms) |
| Feb 3, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Tedd W. Van Buskirk for MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Feb 2, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [326] MOTION for Pro Hac Vice Appearance of Attorney Tedd W. Van Buskirk, filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 2/2/2022. (nms) |
| Feb 1, 2022 | 326 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Tedd W. Van Buskirk - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Weinblatt, Richard) |
| Jan 24, 2022 | N/A | Remark (0) Docket Text: Remark: The filing submitted for in camera review under the cover of D.I. [319] has been destroyed per Defense counsel's consent. (nms) |
| Jan 21, 2022 | 322 | Order (2) Docket Text: ORDER: The request (D.I. [293]) is DENIED. The hearing scheduled for 1/24/2022, is CANCELLED (see Order for further details). Signed by Judge Richard G. Andrews on 1/31/2022. (nms) |
| Jan 21, 2022 | 323 | Main Document (42) Docket Text: AMENDED REDACTED VERSION of [296] Sealed Exhibits, by Sun Pharmaceutical Industries Limited. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) Modified on 1/21/2022 (nms). |
| Jan 21, 2022 | 323 | Certificate of Service (1) |
| Jan 21, 2022 | 324 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s Objections and Responses to Plaintiffs Fourth Set of Common Interrogatories to Defendants (Nos. 10-11) filed by Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) |
| Jan 21, 2022 | 325 | Main Document (6) Docket Text: REDACTED VERSION of [294] Letter, by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Weinblatt, Richard) |
| Jan 21, 2022 | 325 | Exhibit A (12) |
| Jan 21, 2022 | 325 | Exhibit B (11) |
| Jan 21, 2022 | 325 | Exhibit C (138) |
| Jan 21, 2022 | 325 | Exhibit D (35) |
| Jan 20, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The redacted filing (D.I. [317]) is REJECTED because parts of it are redacted in its entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filings are DUE within five business days. Ordered by Judge Richard G. Andrews on 1/20/2022. (nms) |
| Jan 20, 2022 | 319 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from R Touhey Myer, enclosing document for in camera review (see D.I. [311]). (Myer, R.) Modified on 1/20/2022 (nms). |
| Jan 20, 2022 | 320 | Main Document (4) Docket Text: REVISED REDACTED VERSION of [300] Letter, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Exhibits A-E)(Tigan, Jeremy) Modified on 1/20/2022 (nms). |
| Jan 20, 2022 | 320 | Exhibits A-E (48) |
| Jan 20, 2022 | 321 | Order (2) Docket Text: ORDER: Regarding Allegran's request to conduct depositions of individuals employed by Sun and by MSN in India. (D.I. [294], [295], [300], [301]). Since the deponents can provide relevant first-hand testimony, Allergan has been judicious in its use of its allotted time, and the burdens on the deponents and Sun and MSN are not great, the request for protective orders as to Mona Dhaliwal, Sant Singh, and Ashish Malani, all of Sun, and Ravikumar Nithiyanandam and Sajja Eswaraiah of MSN are DENIED. The requests for a protective order as to Devender Dagar of Sun and N. Santhosh Kumar, Rama Mohan, and a further Rule 30(b)(6) deposition as to MSN, which are unopposed, are GRANTED (see Order for other details). Signed by Judge Richard G. Andrews on 1/20/2022. (nms) |
| Jan 19, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The redacted filings (D.I. [312]; D.I. [313]) are REJECTED because parts of them are redacted in their entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filings are DUE within five business days. Ordered by Judge Richard G. Andrews on 1/19/2022. (nms) Modified on 1/26/2022 (nms). |
| Jan 19, 2022 | 315 | Main Document (5) Docket Text: REDACTED VERSION of [301] Letter, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Exhibits A-C)(Tigan, Jeremy) Modified on 1/19/2022 (nms). |
| Jan 19, 2022 | 315 | Exs. A-C (30) |
| Jan 19, 2022 | 316 | Main Document (4) Docket Text: REDACTED VERSION of [293] Letter by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Exhibits A-E)(Tigan, Jeremy) |
| Jan 19, 2022 | 316 | Exhibits A-E (89) |
| Jan 19, 2022 | 317 | Main Document (6) Docket Text: REDACTED VERSION of [294] Letter, by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Weinblatt, Richard) |
| Jan 19, 2022 | 317 | Exhibit A (12) |
| Jan 19, 2022 | 317 | Exhibit B (11) |
| Jan 19, 2022 | 317 | Exhibit C (138) |
| Jan 19, 2022 | 317 | Exhibit D (6) |
| Jan 18, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Aurobindo Defendants are to produce ex parte in camera an unredacted version of D.I. [293] Ex. A as soon as reasonably possible. Ordered by Judge Richard G. Andrews on 1/18/2022. (nms) |
| Jan 18, 2022 | 312 | Main Document (17) Docket Text: REDACTED VERSION of [296] Sealed Exhibits 1-3, by Sun Pharmaceutical Industries Limited. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) Modified on 1/18/2022 (nms). |
| Jan 18, 2022 | 312 | Certificate of Service (1) |
| Jan 18, 2022 | 313 | Main Document (4) Docket Text: REDACTED VERSION of [300] Letter by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Exhibits A-E)(Tigan, Jeremy) |
| Jan 18, 2022 | 313 | Exhibits A-E (36) |
| Jan 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [303] Stipulation and Proposed Order to Modify Scheduling Order. Signed by Judge Richard G. Andrews on 1/14/2022. (nms) |
| Jan 14, 2022 | 303 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedules by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Jan 14, 2022 | 304 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiffs' Fourth Set of Common Interrogatories (Nos. 10-11) [CONFIDENTIAL] filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jan 14, 2022 | 305 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Aurobindo Pharma LTD., Aurobindo Pharma USA, Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, and Zydus Pharmaceuticals (USA) Inc.'s Final Invalidity Contentions regarding U.S. Patent Nos. 11,007,179, 11,090,291, and 11,160,792 filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jan 14, 2022 | 306 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Claim Charts for Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. Relating Each Accused Product to the Asserted Claims filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jan 14, 2022 | 307 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Claim Charts for Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. Relating Each Accused Product to the Asserted Claims filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jan 14, 2022 | 308 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Claim Charts for Defendant Sun Pharmaceutical Industries Limited Relating Each Accused Product to the Asserted Claims filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jan 14, 2022 | 309 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Claim Charts for Defendant Zydus Pharmaceuticals (USA) Inc. Relating Each Accused Product to the Asserted Claims filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jan 14, 2022 | 310 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.s Responses and Objections to Plaintiffs Fourth Set of Common Interrogatories (Nos. 10-11) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Weinblatt, Richard) |
| Jan 13, 2022 | 302 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Joint Interrogatories to Plaintiffs (Nos. 8-9) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jan 12, 2022 | 297 | Stipulation (2) Docket Text: AUTHENTICITY Stipulation and Proposed Order between Plaintiffs and Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc., by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 1/12/2022 (nms). |
| Jan 12, 2022 | 298 | Order (2) Docket Text: SO ORDERED Granting [297] Authenticity Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 1/12/2022. (nms) |
| Jan 12, 2022 | 299 | Main Document (3) Docket Text: Letter to The Honorable Richard G. Andrews, from R Touhey Myer, regarding discovery disputes with Plaintiffs. (Attachments: # (1) Exhibit A)(Myer, R.) Modified on 1/12/2022 (nms). |
| Jan 12, 2022 | 299 | Exhibit A- Declaration of George J. Barry III (4) |
| Jan 10, 2022 | 295 | Letter (5) Docket Text: Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding Sun's Motion for Protective Order. (Gattuso, Dominick) Modified on 1/11/2022 (nms). |
| Jan 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [292] STIPULATION TO EXTEND TIME for the parties to serve their final contentions with respect to the '179 and '291 patents to January 14, 2022. Signed by Judge Richard G. Andrews on 1/7/2022. (nms) |
| Jan 7, 2022 | 292 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to serve their final contentions with respect to the '179 and '291 patents to January 14, 2022 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Jan 3, 2022 | 291 | Order (2) Docket Text: SO ORDERED Granting [289] Authenticity Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 1/3/2022. (nms) |
| Dec 29, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties (Plaintiffs, SUN, MSN, and Aurobindo) have advised that disputes have arisen requiring judicial attention. The Court will hold a discovery conference on 1/24/2022, at 3:30 PM. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. The conference will be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 1/18/2022. Ordered by Judge Richard G. Andrews on 12/29/2021. (nms) |
| Dec 23, 2021 | 289 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Authenticity - by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Dec 20, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael P. Hogan for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Dec 17, 2021 | 288 | Order (3) Docket Text: ORDER: Regarding the weight to be applied to a Patent Examiner's statement, in a Notice of Allowance, about the meaning of a claim (see Order for further details). Signed by Judge Richard G. Andrews on 12/17/2021. (nms) |
| Dec 16, 2021 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 12/16/2021. Counsel for Plaintiffs: J. Tigan. Counsel for Defendants: P. Kraman, R. Weinblatt, D. Gattuso, R. Myer. (Court Reporter Deanna Warner.) (lak) |
| Dec 16, 2021 | 287 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kathleen Waldron, Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, and Philip Erna H. Heyns on a mutually agreed upon date and time (remote) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Dec 15, 2021 | 286 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Fourth Set of Common Interrogatories to Defendants (Nos. 10-11) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Dec 14, 2021 | 285 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Second Set of Joint Interrogatories to Plaintiffs (Nos. 8-9) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Dec 8, 2021 | N/A | Remark (0) Docket Text: Remark: The Markman Hearing scheduled for 12/16/2021, at 9:00 AM will now be held in Courtroom 4A. (lak) |
| Dec 6, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Joint Motion for Claim Construction (D.I. [280]) is Granted, with the exception that the hearing is limited to a total of one and a half hours with each side being allowed 45 minutes. Ordered by Judge Richard G. Andrews on 12/6/2021. (nms) |
| Dec 6, 2021 | 284 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Kenneth L. Dorsney, Cortlan S. Hitch and Morris James LLP for Aurobindo by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Dorsney, Kenneth) |
| Dec 3, 2021 | 279 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions Regarding U.S. Patent Nos. 11,007,179, 11,090,291, and 11,160,792 filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Dec 3, 2021 | 280 | Motion for Miscellaneous Relief (3) Docket Text: Joint Motion for Claim Construction - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 12/6/2021 (nms). |
| Dec 3, 2021 | 281 | Joint Claim Construction Brief (30) Docket Text: JOINT Claim Construction Brief, filed by Eden Biodesign, LLC, Allergan USA, Inc., Allergan Holdings Unlimited Company. (Tigan, Jeremy) Modified on 12/6/2021 (nms). |
| Dec 3, 2021 | 282 | Main Document (3) Docket Text: APPENDIX re [281] Joint Claim Construction Brief, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Exhibit 1 - part 1, # (2) Exhibit 1 - part 2, # (3) Exhibit 2)(Tigan, Jeremy) Modified on 12/6/2021 (nms). |
| Dec 3, 2021 | 282 | Exhibit 1 - Part 1 (138) |
| Dec 3, 2021 | 282 | Exhibit 1 - Part 2 (178) |
| Dec 3, 2021 | 282 | Exhibit 2 (24) |
| Dec 1, 2021 | 278 | Answer to Counterclaim (15) Docket Text: ANSWER to [266] Answer to Amended Complaint, Counterclaim by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Nov 30, 2021 | 276 | Answer to Counterclaim (19) Docket Text: ANSWER to [268] Answer to Amended Complaint and Counterclaims, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) Modified on 12/1/2021 (nms). |
| Nov 30, 2021 | 277 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Weinblatt, Richard) |
| Nov 29, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman Hearing is now rescheduled for 12/16/2021, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 11/29/2021. (nms) |
| Nov 26, 2021 | 274 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Richard Charles Weinblatt on behalf of MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. (Weinblatt, Richard) |
| Nov 18, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Due to a scheduling conflict the Markman hearing scheduled for January 5, 2022, is CANCELED. The Markman hearing will be rescheduled for a date to be determined. Ordered by Judge Richard G. Andrews on 11/18/2021. (nms) |
| Nov 18, 2021 | 273 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Myer, R.) |
| Nov 17, 2021 | 271 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sheker Reddy Alikicherla and Sajja Eswaraiah on dates and times convenient to the parties (First Amended) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Nov 16, 2021 | 270 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Nov 10, 2021 | 264 | Answer to Amended Complaint (11) Docket Text: ANSWER to [255] Amended Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) Modified on 11/10/2021 (nms). |
| Nov 10, 2021 | 265 | Notice (Other) (3) Docket Text: NOTICE of Withdrawal of Beth A. Swadley by Zydus Pharmaceuticals (USA) Inc. (Kraman, Pilar) |
| Nov 10, 2021 | 266 | Answer to Amended Complaint (17) Docket Text: ANSWER to [259] Amended Complaint, Affirmative Defenses and COUNTERCLAIMS against all Plaintiffs, by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) Modified on 11/10/2021 (nms). |
| Nov 10, 2021 | 267 | Answer to Amended Complaint (13) Docket Text: ANSWER to [261] Amended Complaint and Affirmative Defenses, by Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) Modified on 11/10/2021 (nms). |
| Nov 10, 2021 | 268 | Answer to Amended Complaint (21) Docket Text: ANSWER to [257] Amended Complaint, and COUNTERCLAIMS against Allergan Holdings Unlimited Company, Allergan USA, Inc., by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) Modified on 11/12/2021 (nms). |
| Nov 10, 2021 | 269 | Notice of Voluntary Dismissal (2) Docket Text: NOTICE of Voluntary Dismissal by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. as to its inequitable conduct counterclaims and affirmative defenses against Plaintiffs (Stamoulis, Stamatios) |
| Nov 4, 2021 | 263 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant Sun Pharmaceutical Industries Ltd.'s Sixth Set of Interrogatories to Plaintiffs (No. 8) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Nov 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [253] STIPULATION and Proposed Order to Extend Time, filed by Allergan USA, Inc., Eden Biodesign, LLC, Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 11/3/2021. (nms) |
| Nov 3, 2021 | 252 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Construe the Claims of U.S. Patent No. 11,160,792, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 11/3/2021 (nms). |
| Nov 3, 2021 | 253 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 11/3/2021 (nms). |
| Nov 3, 2021 | 254 | Order (3) Docket Text: SO ORDERED Granting [252] Stipulation and Proposed Order to Construe the Claims of U.S. Patent No. 11,160,792. Signed by Judge Richard G. Andrews on 11/3/2021. (nms) |
| Nov 3, 2021 | 255 | Main Document (10) Docket Text: SECOND Amended Complaint against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - filed by Eden Biodesign, LLC, Allergan USA, Inc., Allergan Holdings Unlimited Company. (Attachments: # (1) Exhibits A-C)(Tigan, Jeremy) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 255 | Exhibits A-C (75) |
| Nov 3, 2021 | 256 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2; 11,090,291 B2; 11,160,792 B2. (Tigan, Jeremy) Modified on 11/3/2021 (nms). |
| Nov 3, 2021 | 257 | Main Document (10) Docket Text: SECOND Amended Complaint against MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. - filed by Eden Biodesign, LLC, Allergan USA, Inc., Allergan Holdings Unlimited Company. (Attachments: # (1) Exhibits A-C)(Tigan, Jeremy) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 257 | Exhibits A-C (75) |
| Nov 3, 2021 | 258 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2; 11,090,291 B2; 11,160,792 B2. (Tigan, Jeremy) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 259 | Main Document (9) Docket Text: SECOND Amended Complaint against Sun Pharmaceutical Industries Limited - filed by Eden Biodesign, LLC, Allergan USA, Inc., Allergan Holdings Unlimited Company. (Attachments: # (1) Exhibits A-C)(Tigan, Jeremy) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 259 | Exhibits A-C (75) |
| Nov 3, 2021 | 260 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2; 11,090,291 B2; 11,160,792 B2. (Tigan, Jeremy) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 261 | Main Document (9) Docket Text: SECOND Amended Complaint against Zydus Pharmaceuticals (USA) Inc. - filed by Eden Biodesign, LLC, Allergan USA, Inc., Allergan Holdings Unlimited Company. (Attachments: # (1) Exhibits A-C)(Tigan, Jeremy) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 261 | Exhibits A-C (75) |
| Nov 3, 2021 | 262 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2; 11,090,291 B2; 11,160,792 B2. (Tigan, Jeremy) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 257 | Amended Complaint* (1) |
| Nov 3, 2021 | 261 | Amended Complaint* (1) |
| Nov 3, 2021 | 255 | Amended Complaint* (1) |
| Nov 3, 2021 | 259 | Amended Complaint* (1) |
| Nov 2, 2021 | 251 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Answering Claim Construction Brief filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Oct 20, 2021 | 249 | Stipulation of Dismissal (5) Docket Text: STIPULATION of Dismissal between Plaintiffs and Defendants Hetero Labs Limited and Hetero USA, Inc., by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/20/2021 (nms). |
| Oct 20, 2021 | 250 | Order (5) Docket Text: SO ORDERED Granting [249] Stipulation of Dismissal (*Party Hetero USA Inc., and Hetero Labs Limited terminated). Signed by Judge Richard G. Andrews on 10/20/2021. (nms) |
| Oct 19, 2021 | 248 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Opening Claim Construction Brief and the (2) Expert Declaration of Cory Berkland, Ph.D. - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Oct 18, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [247] MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. Signed by Judge Richard G. Andrews on 10/18/2021. (nms) |
| Oct 18, 2021 | 246 | Order (5) Docket Text: SO ORDERED Granting [245] Stipulation and Order (*Party Alkem Laboratories Limited terminated). Signed by Judge Richard G. Andrews on 10/18/2021. (nms) |
| Oct 18, 2021 | 247 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Oct 15, 2021 | 245 | Stipulation of Dismissal (5) Docket Text: STIPULATION of Dismissal between Plaintiffs and Defendant Alkem Laboratories Limited, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 10/15/2021 (nms). |
| Oct 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [244] STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.'s Counterclaims (D.I. 233) to November 17, 2021. Signed by Judge Richard G. Andrews on 10/12/2021. (nms) |
| Oct 11, 2021 | 244 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.'s Counterclaims (D.I. 233) to November 17, 2021 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Oct 5, 2021 | 242 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Sixth Set of Interrogatories to Plaintiffs (No. 8) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Oct 5, 2021 | 243 | Main Document (9) Docket Text: Joint Claim Construction Chart, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Exhibits A-J)(Tigan, Jeremy) Modified on 10/6/2021 (nms). |
| Oct 5, 2021 | 243 | Exhibits A-J (271) |
| Oct 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [239] STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to Defendants Hetero Labs Limited and Hetero USA Inc.'s Counterclaims to November 3, 2021. Signed by Judge Richard G. Andrews on 10/4/2021. (nms) |
| Oct 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [240] STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.'s Counterclaims to November 3, 2021. Signed by Judge Richard G. Andrews on 10/4/2021. (nms) |
| Oct 4, 2021 | 239 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to Defendants Hetero Labs Limited and Hetero USA Inc.'s Counterclaims (D.I. 228) to November 3, 2021 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Oct 4, 2021 | 240 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.'s Counterclaims (D.I. 233) to November 3, 2021 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Oct 4, 2021 | 241 | Answer to Counterclaim (12) Docket Text: ANSWER to [230] Answer to Complaint, Counterclaim by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Sep 28, 2021 | 237 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Joint Requests for Production Regarding the '179 and '291 Patents (Nos. 1-11) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Sep 28, 2021 | 238 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Joint Disclosure of Proposed Claim Terms and Their Proposed Construction filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Sep 27, 2021 | 236 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Supplemental Responses and Objections to Plaintiffs' Individual Interrogatories (Nos. 1-2) and Common Interrogatories (Nos. 3,4,6,7,8, and 9) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Sep 24, 2021 | 235 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Individuals listed in notice on dates and times convenient to the parties (First Amended) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Sep 20, 2021 | 234 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Claim Charts for Defendant Alkem Laboratories Limited Relating Each Accused Product to the Asserted Claims, (2) Plaintiffs' Initial Claim Charts for Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. Relating Each Accused Product to the Asserted Claims, (3) Plaintiffs' Initial Claim Charts for Defendants Hetero Labs Limited and Hetero USA Inc. Relating Each Accused Product to the Asserted Claims, (4) Plaintiffs' Initial Claim Charts for Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. Relating Each Accused Product to the Asserted Claims, (5) Plaintiffs' Initial Claim Charts for Defendant Sun Pharmaceutical Industries Limited Relating Each Accused Product to the Asserted Claims, and (6) Plaintiffs' Initial Claim Charts for Defendant Zydus Pharmaceuticals (USA) Inc. Relating Each Accused Product to the Asserted Claims filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Sep 14, 2021 | 232 | Answer to Complaint (17) Docket Text: ANSWER to First Amended Complaint and COUNTERCLAIMS against all Plaintiffs, by Alkem Laboratories Limited.(Phillips, John) Modified on 9/14/2021 (nms). |
| Sep 14, 2021 | 233 | Answer to Complaint (30) Docket Text: ANSWER to Complaint, Affirmative Defenses, and COUNTERCLAIMS against Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) Modified on 9/15/2021 (nms). |
| Sep 13, 2021 | 228 | Answer to Complaint (27) Docket Text: Answer to First Amended Complaint, Affirmative Defenses and Counterclaims for the '179 and '291 Patents (see C.A. No. 21-1063-RGA) against All Plaintiffs, by Hetero USA Inc., Hetero Labs Limited.(Dorsney, Kenneth) Modified on 9/13/2021 (nms). |
| Sep 13, 2021 | 229 | Answer to Complaint (11) Docket Text: ANSWER to First Amended Complaint (see C.A. No. 21-1062), by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) Modified on 9/14/2021 (nms). |
| Sep 13, 2021 | 230 | Answer to Complaint (15) Docket Text: ANSWER to Complaint (see C.A. No. 21-1065) and COUNTERCLAIMS against All Plaintiffs, by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) Modified on 9/14/2021 (nms). |
| Sep 13, 2021 | 231 | Answer to Complaint (10) Docket Text: ANSWER to Complaint (see C.A. No. 21-1066-RGA), by Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) Modified on 9/14/2021 (nms). |
| Sep 10, 2021 | 227 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant Sun Pharmaceutical Industries Ltd.'s Fifth Set of Interrogatories to Plaintiffs (No. 7) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Aug 30, 2021 | 226 | Order (7) Docket Text: SO ORDERED Granting (D.I. 15 in 21-cv-1062-RGA; D.I. 12 in 21-cv-1064-RGA; D.I. 12 in 21-cv-1061-RGA; D.I. 225 in 19-cv-1727-RGA; D.I. 11 in 21-cv-1065-RGA; D.I. 13 in 21-cv-1066-RGA; D.I. 12 in 21-cv-1063-RGA) Stipulation and Proposed Order to Consolidate and Extend Time (*Reset Deadlines/Hearings: Joint Claim Construction Brief due by 12/3/2021, Pretrial Order due by 10/11/2022, Status letter due by 7/6/2022, A Bench Trial is set to start 11/7/2022, at 8:30 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:19-cv-01727-RGA et al.(nms) |
| Aug 27, 2021 | 224 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' first set of joint requests for production '179 and '291 Patents (Nos. 1-11) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Aug 27, 2021 | 225 | Main Document (7) Docket Text: STIPULATION and [Proposed] Order to Consolidate and Extend Time, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Letter)(Tigan, Jeremy) Modified on 8/30/2021 (nms). |
| Aug 27, 2021 | 225 | Letter to Judge Andrews (2) |
| Aug 20, 2021 | 223 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Greg J. Winter as co-counsel. Reason for request: Left Firm. (Gattuso, Dominick) |
| Aug 16, 2021 | 221 | Order (3) Docket Text: SO ORDERED Granting [219] Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 8/16/2021. (nms) |
| Aug 16, 2021 | 222 | Order (3) Docket Text: SO ORDERED Granting (D.I. 218 in 19-cv-1727-RGA; 74 in D.I. 19-cv-1674-RGA) Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 8/16/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Aug 12, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The conference scheduled for 8/20/2021, is CANCELED. The parties have advised that the dispute has been resolved. Ordered by Judge Richard G. Andrews on 8/12/2021. (nms) |
| Aug 11, 2021 | 218 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Aug 11, 2021 | 219 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Aug 10, 2021 | 216 | Stipulation (2) Docket Text: Authenticity Stipulation and [Proposed] Order, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 8/10/2021 (nms). |
| Aug 10, 2021 | 217 | Order (2) Docket Text: SO ORDERED Granting [216] Authenticity Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 8/10/2021. (nms) |
| Aug 6, 2021 | 215 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Fifth Set of Interrogatories to Plaintiffs (No.7) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jul 28, 2021 | 213 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant Alkem Laboratories Limited's First Set of Requests for Admission (Nos. 1-6) and (2) Plaintiffs' Objections and Responses to Defendant Alkem Laboratories Limited's Second Set of Individual Interrogatories (Nos. 4-7) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jul 28, 2021 | 214 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant Sun Pharmaceutical Industries Ltd.'s Second Set of Request for Admissions to Plaintiffs (Nos. 3-5) and (2) Plaintiffs' Objections and Responses to Defendant Sun Pharmaceutical Industries Ltd.'s Fourth Set of Interrogatories to Plaintiffs (Nos. 4-6) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.(Tigan, Jeremy) |
| Jul 22, 2021 | 211 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Responses and Objections to Plaintiffs' Third Set of Common Interrogatories (No. 9) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jul 22, 2021 | 212 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant Sun Pharmaceutical Industries Ltd.'s First Set of Requests for Admissions (Nos. 1-2) and (2) Plaintiffs' Objections and Responses to Defendant Sun Pharmaceutical Industries Ltd.'s Third Interrogatory to Plaintiff (No. 3) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jul 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [208] STIPULATION and Proposed Order (see Stipulation for details). Signed by Judge Richard G. Andrews on 7/21/2021. (nms) |
| Jul 21, 2021 | 209 | Stipulation (2) Docket Text: Authenticity Stipulation and [Proposed] Order between Plaintiffs and Hetero Labs Limited and Hetero USA Inc., by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Tigan, Jeremy) Modified on 7/21/2021 (nms). |
| Jul 21, 2021 | 210 | Order (2) Docket Text: SO ORDERED Granting [209] Authenticity Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 7/21/2021. (nms) |
| Jul 20, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties have advised that a dispute has arisen requiring judicial attention. The Court will hold a discovery conference on 8/20/2021, at 2:00 PM. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. The conference will be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 8/10/2021. Ordered by Judge Richard G. Andrews on 7/20/2021. (nms) |
| Jul 20, 2021 | 208 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Tigan, Jeremy) Modified on 7/21/2021 (nms). |
| Jul 19, 2021 | 205 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s Objections and Response to Plaintiffs' Third Set of Common Interrogatories to Defendants (No. 9) filed by Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth) |
| Jul 19, 2021 | 206 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(1) and [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Alkem Laboratories Limited.(Bilson, David) |
| Jul 16, 2021 | 199 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's [CONFIDENTIAL] Objections and Responses to Plaintiffs' Third Set of Common Interrogatories to Alkem (No. 9) filed by Alkem Laboratories Limited.(Bilson, David) |
| Jul 16, 2021 | 200 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's Objections and Responses to Plaintiffs' Third Set of Common Interrogatories (No. 9) filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Jul 16, 2021 | 201 | Stipulation (2) Docket Text: Authenticity Stipulation and [Proposed] Order, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Tigan, Jeremy) Modified on 7/16/2021 (nms). |
| Jul 16, 2021 | 202 | Order (2) Docket Text: SO ORDERED Granting [201] Authenticity Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 7/16/2021. (nms) |
| Jul 16, 2021 | 203 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiffs' Third Set of Common Interrogatories (No. 9) [CONFIDENTIAL] filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jul 16, 2021 | 204 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.s Responses and Objections to Plaintiffs Third Set of Common Interrogatories (No. 9) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Jul 8, 2021 | 197 | Order (2) Docket Text: SO ORDERED Granting [196] Stipulation and Order to not exchange privilege logs. Signed by Judge Richard G. Andrews on 7/8/2021. (nms) |
| Jul 8, 2021 | 198 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Zydus Pharmaceuticals (USA) Inc.'s Objections and Responses to Plaintiffs' Notice of the Deposition of Zydus Pharmaceuticals (USA) Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth) |
| Jul 7, 2021 | 196 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to not exchange privilege logs by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Stamoulis, Stamatios) |
| Jul 6, 2021 | 195 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-7) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jul 2, 2021 | 194 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendant Sun Pharmaceutical Industries Ltd.'s Second Interrogatory to Plaintiffs (No. 2) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 30, 2021 | 192 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kerri Kaplan, Kathleen Waldron and Tim Costello filed by Alkem Laboratories Limited.(Bilson, David) |
| Jun 30, 2021 | 193 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Final Invalidity Contentions filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jun 28, 2021 | 190 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Limited's Second Set of Individual Interrogatories (Nos. 4-7) and Alkem Laboratories Limited's [CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] First Set of Requests for Admission (Nos. 1-6) filed by Alkem Laboratories Limited.(Bilson, David) |
| Jun 28, 2021 | 191 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Sun Pharmaceutical Industries Ltd.'s Second Set of Requests for Admission (Nos. 3-5) [CONFIDENTIAL]; and, (ii) Defendant Sun Pharmaceutical Industries Ltd.'s Fourth Set of Interrogatories to Plaintiffs (Nos. 4- 6) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jun 24, 2021 | 189 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 23, 2021 | 188 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.s Supplemental Responses to Plaintiffs Interrogatories (Nos. 3, 4, 6, and 7) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Jun 22, 2021 | 187 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Sun Pharmaceutical Industries Ltd.'s Third Interrogatory to Plaintiffs (No. 3); and, (ii) Defendant Sun Pharmaceutical Industries Ltd.'s First Set of Requests for Admission (Nos. 1-2) [CONFIDENTIAL] filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jun 21, 2021 | 185 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Zydus Pharmaceuticals (USA) Inc.'s Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (No. 8); and 2) Zydus Pharmaceuticals (USA) Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories to Defendant Zydus Pharmaceuticals (USA) Inc. (Nos. 1-2) filed by Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth) |
| Jun 21, 2021 | 186 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Responses and Objections to Plaintiffs' Notice of 30(b)(6) Deposition filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 18, 2021 | 184 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Alkem Laboratories Limited.(Bilson, David) |
| Jun 16, 2021 | 183 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Third Set of Common Interrogatories to Defendants (No. 9) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 15, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for D.I. [182] has been replaced per counsel's request. A notice intended for another matter was inadvertently uploaded in the first instance. The NEF for the filing has been regenerated. (nms) |
| Jun 15, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for D.I. [178] has been replaced with a corrected version per counsel's request. The NEF for the filing has been regenerated. (nms) |
| Jun 14, 2021 | 175 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Alkem (No. 8) and Defendant Alkem Laboratories Limited's Objections and Responses to Plaintiffs' First Set of Interrogatories to Alkem (Nos. 1-2) filed by Alkem Laboratories Limited.(Bilson, David) |
| Jun 14, 2021 | 176 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's Objections and Responses to Plaintiffs' Notice of 30(b)(6) Deposition filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Jun 14, 2021 | 177 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's objections and responses to Plaintiffs' Second Set of Common Interrogatories (No. 8) filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Jun 14, 2021 | 178 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiffs First Set of Common Interrogatories; and, (ii) Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiffs' Second Set of Common Interrogatories (No. 8) [CONFIDENTIAL] filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) (Main Document 178 replaced on 6/15/2021) (nms). (Main Document 178 replaced on 6/15/2021) (nms). |
| Jun 14, 2021 | 179 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jun 14, 2021 | 180 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-2) and; (2) Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Responses and Objections to Plaintiffs' Second Set of Common Interrogatories (No. 8) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 14, 2021 | 181 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Notice of Rule 30(b)(6) Deposition of Plaintiffs filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 14, 2021 | 182 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.s Objections and Response to Plaintiffs Notice of the Deposition of Pursuant to Fed. R. Civ. P. 30(B)(6), (2) Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.s Responses and Objections to Plaintiffs Second Set of Common Interrogatories (No. 8), and (3) Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.s Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-2) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) (Main Document 182 replaced on 6/15/2021) (nms). |
| Jun 9, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ronald M. Daignault,Richard Juang for MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Jun 4, 2021 | 174 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Supplemental Responses and Objections to Plaintiffs' First Set of Common Interrogatories (Nos. 3-7) [CONFIDENTIAL] filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jun 3, 2021 | 172 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, and Eden Biodesign, LLC on at a time and place to be mutually agreed upon by counsel filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jun 3, 2021 | 173 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-7) [CONFIDENTIAL] filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jun 1, 2021 | 166 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Notice to Zydus Pharmaceuticals (USA) Inc. of Depositions Pursuant to Federal Rule of Civil Procedure 30(b)(1) and (2) Plaintiffs' Notice of the Deposition of Zydus Pharmaceuticals (USA) Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 1, 2021 | 167 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Notice to MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. of Depositions Pursuant to Federal Rule of Civil Procedure 30(b)(1) and (2) Plaintiffs' Notice of the Deposition of MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 1, 2021 | 168 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Notice to Alkem Laboratories Limited of Depositions Pursuant to Rule of Civil Procedure 30(b)(1) and (2) Plaintiffs' Notice of the Deposition of Alkem Laboratories Limited Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 1, 2021 | 169 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Notice of the Deposition of Sun Pharmaceutical Industries Limited Pursuant to Fed. R. Civ. P. 30(b)(6) and (2) Plaintiffs' Notice to Sun Pharmaceutical Industries Limited of Depositions Pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 1, 2021 | 170 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Notice of the Deposition of Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) and (2) Plaintiffs' Notice to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. of Depositions Pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 1, 2021 | 171 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Notice to Hetero Labs Limited and Hetero USA Inc. of Depositions Pursuant to Federal Rule of Civil Procedure 30(b)(1) and (2) Plaintiffs' Notice of the Deposition of Hetero Labs Limited and Hetero USA, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| May 25, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin J. Boyle for Sun Pharmaceutical Industries Limited and for Sun Pharmaceutical Industries Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01479-RGA, 1:19-cv-01727-RGA(mal) |
| May 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 164 in 19-cv-1727-RGA; D.I. 39 in 20-cv-1479-RGA) MOTION for Pro Hac Vice Appearance of Attorney Kevin J. Boyle of Winston & Strawn LLP, filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited. Signed by Judge Richard G. Andrews on 5/21/2021. Associated Cases: 1:19-cv-01727-RGA, 1:20-cv-01479-RGA(nms) |
| May 21, 2021 | 164 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin J. Boyle of Winston & Strawn LLP - filed by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| May 21, 2021 | 165 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of supplemental responses to subset (Nos. 5-7) of First Set of Common Interrogatories (Nos. 1-7) filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| May 17, 2021 | 162 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Common Interrogatories to Defendants (No. 8) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| May 17, 2021 | 163 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants and Supplemental Objections and Responses to Alkem's Interrogatory Nos. 1-2 filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| May 14, 2021 | 161 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Alkem (Nos. 6-7) filed by Alkem Laboratories Limited.(Bilson, David) |
| Apr 26, 2021 | 159 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Kenneth Laurence Dorsney (Dorsney, Kenneth) |
| Apr 26, 2021 | 160 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant Sun Pharmaceutical Industry Ltd.'s Second Interrogatory to Plaintiff (No. 2) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Apr 23, 2021 | 158 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Hetero Labs Limited and Hetero USA, Inc.'s First Set of Interrogatories to Plaintiffs (No. 1) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Apr 14, 2021 | 157 | Notice (Other) (7) Docket Text: NOTICE of Withdrawal of Counsel by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV (Tigan, Jeremy) |
| Apr 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (154 in 19-cv-1727-RGA; 33 in 20-cv-1479-RGA; 38 in 20-cv-1344-RGA) MOTION for Pro Hac Vice Appearance of Attorney Hassen Sayeed, Daniel O'Boyle, Carolyn Wall, James Yi Li and Mark A. Hayden of O'Melveny & Myers LLP, filed by Janssen Pharmaceutica NV, Allergan Pharmaceuticals International Limited, Eden Biodesign, LLC., Allergan USA, Inc., Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 4/5/2021. Associated Cases: 1:19-cv-01727-RGA, 1:20-cv-01344-RGA, 1:20-cv-01479-RGA(nms) |
| Apr 5, 2021 | 156 | Order (5) Docket Text: SO ORDERED as modified re (D.I. 31 in 20-cv-1479-RGA; D.I. 36 in 20-cv-1344-RGA; D.I. 152 in 19-cv-1727-RGA) Stipulation and Proposed Order to Modify Case Schedules. Signed by Judge Richard G. Andrews on 4/5/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA, 1:20-cv-01344-RGA, 1:20-cv-01479-RGA(nms) |
| Apr 2, 2021 | 153 | Notice Requesting Removal of Co-Counsel (7) Docket Text: NOTICE requesting Clerk to remove Amanda K. Antons as co-counsel. Reason for request: No Longer with Firm. (Tigan, Jeremy) |
| Apr 2, 2021 | 154 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Hassen Sayeed, Daniel O'Boyle, Carolyn Wall, James Yi Li and Mark A. Hayden of O'Melveny & Myers LLP - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Apr 2, 2021 | 155 | Notice (Other) (6) Docket Text: NOTICE of Appearance of Lisa B. Pensabene of O'Melveny & Myers LLP by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV (Tigan, Jeremy) |
| Mar 31, 2021 | 152 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedules by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Mar 12, 2021 | 151 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Second Interrogatory to Plaintiffs (No. 2) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Mar 10, 2021 | 150 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's First Set of Interrogatories to Plaintiffs (No. 1) filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Feb 26, 2021 | 149 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Zachary B. Cohen of Winston & Strawn LLP as co-counsel. Reason for request: Left Firm. (Gattuso, Dominick) |
| Feb 12, 2021 | 148 | Notice (Other) (2) Docket Text: NOTICE of of Change of Law Firm Affiliation by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. (Stamoulis, Stamatios) |
| Feb 8, 2021 | 147 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions for U.S. Patent No. 9,675,587 filed by Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth) |
| Jan 27, 2021 | 146 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC's Objections and Responses to Defendant Alkem Laboratories Limited's First Set of Individual Interrogatories (Nos. 1-3) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jan 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 56 in 19-cv-1674-RGA; D.I. 143 in 19-cv-1727-RGA) STIPULATION for Extension of Time between Plaintiffs and Aurobindo to substantially complete document production to January 19, 2021. Signed by Judge Richard G. Andrews on 1/13/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Jan 13, 2021 | 144 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiffs First Set of Common Interrogatories filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jan 13, 2021 | 145 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Response to Plaintiffs First Set of Common Interrogatories (Nos. 1-7) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Jan 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 55 in 19-cv-1674-RGA; D.I. 142 in 19-cv-1727-RGA) STIPULATION for Extension of Time for the substantial completion of document production to January 12, 2021. Signed by Judge Richard G. Andrews on 1/12/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Jan 12, 2021 | 143 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION for Extension of Time - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 1/13/2021 (nms). |
| Jan 11, 2021 | 140 | Memorandum Opinion (16) Docket Text: MEMORANDUM OPINION providing claim construction for various terms in U.S. Patent Nos. 8,691,860, 9,115,091, 9,364,489, 9,789,125, 9,675,587, and 10,188,632.. Signed by Judge Richard G. Andrews on 1/11/2021. (nms) |
| Jan 11, 2021 | 141 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Responses and Objections to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-7) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jan 11, 2021 | 142 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION for Extension of Time for the substantial completion of document production to January 12, 2021 (between Plaintiffs and Aurobindo only) - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 1/12/2021 (nms). |
| Jan 8, 2021 | 139 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responses to first set of common interrogatories (Nos. 1-7) filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Dec 30, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notice of Service filed at D.I. 138 has been removed from the docket per Counsel's request. This filing was duplicative of the notice already on file at D.I. [137]. (nms) |
| Dec 30, 2020 | 136 | Transcript (90) Docket Text: Official Transcript of Markman Hearing Videoconference held on 12/21/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/20/2021. Redacted Transcript Deadline set for 2/1/2021. Release of Transcript Restriction set for 3/30/2021. (Triozzi, Heather) |
| Dec 30, 2020 | 137 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's [CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Alkem (Nos. 1-7) filed by Alkem Laboratories Limited.(Bilson, David) |
| Dec 30, 2020 | 138 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s Objections and Responses to Plaintiffs First Set of Common Interrogatories to Defendants (Nos. 1- 7) filed by Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth) |
| Dec 28, 2020 | 135 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Limited's [CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] First Set of Individual Interrogatories (Nos. 1-3) filed by Alkem Laboratories Limited.(Bilson, David) |
| Dec 21, 2020 | N/A | Remark (0) Docket Text: Remark: The public may access the hearing scheduled for 12/21/2020, at 10:00 a.m. by dialing the following phone number: +1 202-503-1666, then enter Conference ID: 153315280#. The dial-in information provides listening capabilities only. (lak) |
| Dec 21, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 12/21/2020. Counsel for Plaintiffs: J. Tigan. Counsel for Defendants: K. Dorsney, J. Phillips, P. Kraman, D. Gattuso, S. Stamoulis. (Court Reporter Heather Triozzi.) (lak) |
| Dec 11, 2020 | 134 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Sun Pharmaceutical Industries Limited's Amended Rule 26(a)(1) Initial Disclosures; and, (ii) Defendant Sun Pharmaceutical Industries Limited's Amended Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Nov 30, 2020 | 133 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-7) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Nov 24, 2020 | 132 | Order (3) Docket Text: SO ORDERED Granting [128] Joint Motion for Claim Construction. Signed by Judge Richard G. Andrews on 11/24/2020. (nms) |
| Nov 23, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman hearing scheduled for December 21, 2020, will now be held using Skype for business. A joint email with the email addresses for all those participating in the hearing shall be due to the Court's Case Manager by 4:00 PM on 12/14/2020. Ordered by Judge Richard G. Andrews on 11/23/2020. (nms) |
| Nov 23, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Due to a scheduling conflict the Markman Hearing set for 12/21/2020, will now begin at 10:00 AM. The hearing is limited to two hours. Ordered by Judge Richard G. Andrews on 11/23/2020. (nms) |
| Nov 23, 2020 | 128 | Motion for Miscellaneous Relief (3) Docket Text: Joint Motion for Claim Construction - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Tigan, Jeremy) Modified on 11/24/2020 (nms). |
| Nov 23, 2020 | 129 | Joint Claim Construction Brief (30) Docket Text: Joint Claim Construction Brief, filed by Eden Biodesign, LLC., Allergan USA, Inc., Allergan Holdings Unlimited Company. (Tigan, Jeremy) Modified on 11/24/2020 (nms). |
| Nov 23, 2020 | 130 | Main Document (428) Docket Text: APPENDIX, Volume 1 of 2 re [129] Joint Claim Construction Brief, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Attachments: # (1) Exhibits R-V)(Tigan, Jeremy) Modified on 11/24/2020 (nms). |
| Nov 23, 2020 | 130 | Exhibit R-V (93) |
| Nov 23, 2020 | 131 | Appendix (30) Docket Text: APPENDIX, Volume 2 of 2 re [129] Joint Claim Construction Brief, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Tigan, Jeremy) Modified on 11/24/2020 (nms). |
| Nov 17, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [125] STIPULATION and Proposed Order to substantially complete document production to January 11, 2021. Signed by Judge Richard G. Andrews on 11/17/2020. (nms) |
| Nov 17, 2020 | 125 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to substantially complete document production to January 11, 2021 - filed by Alkem Laboratories Limited. (Bilson, David) |
| Nov 5, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The brief filed at D.I. 124 has been rejected. The brief is to be served not filed. (nms) |
| Nov 5, 2020 | 124 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Oct 23, 2020 | 122 | Transcript (22) Docket Text: Official Transcript of Discovery Dispute Videoconference held on 10/8/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/13/2020. Redacted Transcript Deadline set for 11/23/2020. Release of Transcript Restriction set for 1/21/2021. (Triozzi, Heather) |
| Oct 23, 2020 | 123 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.s Responses and Objections to the Request for Production served by Defendants Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Alkem Laboratories Limited, Hetero Labs Limited, Hetero USA Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., and Zydus Pharmaceuticals (USA) Inc. filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Oct 16, 2020 | 121 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Response to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc., Alkem Laboratories Limited, Hetero Labs Limited and Hetero USA Inc., MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc., and Zydus Pharmaceuticals (USA) Inc.'s Joint Request for the Production of Documents and Things filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Oct 13, 2020 | 120 | Order (2) Docket Text: ORDER: Plaintiffs' letter seeking dismissal of Defendants' invalidity defenses and counterclaims is DENIED (see Order for further details). Signed by Judge Richard G. Andrews on 10/13/2020. (nms) |
| Oct 8, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Discovery Conference held on 10/8/2020. Counsel for Plaintiffs: J. Tigan. Counsel for Defendants: D. Gattuso, P. Kraman. (Court Reporter Heather Triozzi.) (lak) |
| Oct 8, 2020 | 119 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Oct 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [118]S TIPULATION to serve reply claim construction brief to October 8, 2020, and to serve sur-reply claim construction brief to November 5, 2020. Signed by Judge Richard G. Andrews on 10/2/2020. (nms) |
| Oct 2, 2020 | 118 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION to serve reply claim construction brief to October 8, 2020, and to serve sur-reply claim construction brief to November 5, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Tigan, Jeremy) Modified on 10/2/2020 (nms). |
| Oct 1, 2020 | 117 | Main Document (5) Docket Text: Letter to The Honorable Richard G. Andrews from Pilar G. Kraman regarding Defendants' Responsive Letter Regarding Invalidity Contentions. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Kraman, Pilar) |
| Oct 1, 2020 | 117 | Exhibit 1 (12) |
| Oct 1, 2020 | 117 | Exhibit 2 (2) |
| Oct 1, 2020 | 117 | Text of Proposed Order (2) |
| Sep 29, 2020 | 116 | Main Document (5) Docket Text: Letter to The Honorable Judge Richard G. Andrews from Jeremy A. Tigan regarding Invalidity Contentions. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit 1-9)(Tigan, Jeremy) |
| Sep 29, 2020 | 116 | Text of Proposed Order (2) |
| Sep 29, 2020 | 116 | Exhibit 1-9 (52) |
| Sep 17, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties have advised that a dispute has arisen requiring judicial attention. The Court will hold a discovery conference on 10/8/2020, at 2:00 PM. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. The conference will be held using Skype for business. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 10/1/2020. Ordered by Judge Richard G. Andrews on 9/17/2020. (nms) |
| Sep 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 111 in 19-cv-1727-RGA; D.I. 49 in 19-cv-1674-RGA)MOTION for Pro Hac Vice Appearance of Attorney Amanda K. Antons, filed by Janssen Pharmaceutica NV, Allergan Pharmaceuticals International Limited, Eden Biodesign, LLC., Allergan USA, Inc., Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 9/16/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Sep 16, 2020 | 111 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amanda K. Antons - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Sep 16, 2020 | 112 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Response to Sun Pharmaceutical Industry Ltd.'s First Interrogatory to Plaintiffs (No. 1) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Sep 16, 2020 | 113 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Alkem Laboratories Limited, Hetero Labs Limited, Hetero USA Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., and Zydus Pharmaceuticals (USA) Inc.s Joint Requests for the Production of Documents and Things filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Weinblatt, Richard) |
| Sep 16, 2020 | 114 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Alkem Laboratories Limited, Hetero Labs Limited, Hetero USA Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., and Zydus Pharmaceuticals (USA) Inc.s Joint Requests for the Production of Documents and Things to Sun Pharmaceutical Industries Limited filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Sep 2, 2020 | 110 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Aug 24, 2020 | 109 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of response to second set of requests for production (Nos. 12-94) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Aug 11, 2020 | 108 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s Objections and Responses to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos.890) filed by Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth) |
| Aug 10, 2020 | 105 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's [CONFIDENTIAL] Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 10-92) filed by Alkem Laboratories Limited.(Bilson, David) |
| Aug 10, 2020 | 106 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharmaceutical Industries Ltd.s Responses and Objections to Plaintiffs Second set of Requests for Production filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Aug 10, 2020 | 107 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Response to Plaintiffs Response to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 12-94) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Aug 5, 2020 | 104 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Aug 3, 2020 | 102 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's response to Plaintiffs' Second Set of Requests for Production filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Aug 3, 2020 | 103 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sun Pharmaceutical Industries Ltd.s First Interrogatory to Plaintiffs (No. 1) filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jul 22, 2020 | 101 | Main Document (14) Docket Text: JOINT Claim Construction Chart, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Attachments: # (1) Exhibit 1-6, # (2) Exhibit 7-16, # (3) Exhibit 17-25, # (4) Exhibit 26-30, # (5) Exhibit 31)(Tigan, Jeremy) Modified on 7/23/2020 (nms). |
| Jul 22, 2020 | 101 | Exhibit 1-6 (104) |
| Jul 22, 2020 | 101 | Exhibit 7-16 (406) |
| Jul 22, 2020 | 101 | Exhibit 17-25 (75) |
| Jul 22, 2020 | 101 | Exhibit 26-30 (52) |
| Jul 22, 2020 | 101 | Exhibit 31 (28) |
| Jul 21, 2020 | 100 | Order (30) Docket Text: SO ORDERED Granting [99] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 7/21/2020. (nms) |
| Jul 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (98 in 19-cv-1727-RGA; 42 in 19-cv-1674-RGA) Stipulation and Order to Extend Time. Signed by Judge Richard G. Andrews on 7/20/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Jul 20, 2020 | 97 | Memorandum and Order (1) Docket Text: MEMORANDUM ORDER: I adopt Defendants' position regarding a dispute about the protective order. A proposed protective order is to be resubmitted in conformity with that ruling. Signed by Judge Richard G. Andrews on 7/20/2020. (nms) |
| Jul 20, 2020 | 98 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to File Joint Claim Construction Chart to July 22, 2020 - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Jul 20, 2020 | 99 | Proposed Order (30) Docket Text: PROPOSED Stipulated Protective Order, by Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) Modified on 7/21/2020 (nms). |
| Jul 15, 2020 | 96 | Main Document (6) Docket Text: Joint Letter to The Honorable Richard G. Andrews from Jeremy A. Tigan regarding Protective Order Dispute. (Attachments: # (1) Exhibit A-F and 1-6)(Tigan, Jeremy) |
| Jul 15, 2020 | 96 | Exhibit A-F and 1-6 (155) |
| Jul 13, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Gregory J. Winter for Sun Pharmaceutical Industries Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jul 9, 2020 | 95 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for the Production of Documents and Things to Defendants filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jul 8, 2020 | 93 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Joint Claim Terms for Construction and Proposed Constructions filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Jul 8, 2020 | 94 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Claim Construction Issue Identification filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 26, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [91] MOTION for Pro Hac Vice Appearance of Attorney Gregory J. Winter, filed by Sun Pharmaceutical Industries Limited. Signed by Judge Richard G. Andrews on 6/26/2020. (nms) |
| Jun 26, 2020 | 91 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gregory J. Winter - filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) |
| Jun 26, 2020 | 92 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.s Initial Invalidity Contentions filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jun 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [90] STIPULATION TO EXTEND TIME for the Parties to Submit a Proposed Protective Order to June 26, 2020. Signed by Judge Richard G. Andrews on 6/22/2020. (nms) |
| Jun 19, 2020 | 89 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Joint Requests for the Production of Documents and Things to Plaintiffs (Nos. 1-58) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jun 19, 2020 | 90 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to Submit a Proposed Protective Order to June 26, 2020 - filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) |
| Jun 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (36 in 19-cv-1674-RGA; 88 in 19-cv-01727-RGA) STIPULATION and Order to Extend Time to submit Proposeed Protective Order to June 19, 2020. Signed by Judge Richard G. Andrews on 6/5/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Jun 5, 2020 | 88 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Order to Extend Time to submit Proposed Protective Order to June 19, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 6/5/2020 (nms). |
| May 26, 2020 | 87 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts Relating Each Accused Product to the Asserted Claims (served on various defendants as outlined in notice) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| May 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (86 in 19-cv-1727-RGA; 34 in 19-cv-1674-RGA) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to June 5, 2020. Signed by Judge Richard G. Andrews on 5/22/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| May 22, 2020 | 86 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to June 5, 2020 - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| May 15, 2020 | 85 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Blumenfeld, Jack) |
| May 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (32 in 19-cv-1674-RGA; 84 in 19-cv-1727-RGA) STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to May 22, 2020. Signed by Judge Richard G. Andrews on 5/11/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| May 11, 2020 | 84 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to May 22, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| May 8, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Timothy H. Kratz and George J. Barry, III for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| May 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [83] MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. Signed by Judge Richard G. Andrews on 5/6/2020. (nms) |
| May 5, 2020 | 83 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Apr 28, 2020 | 82 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Joint Requests for the Production of Documents and Things (Nos. 1-58) filed by Alkem Laboratories Limited.(Bilson, David) |
| Apr 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (30 in 19-cv-1674-RGA; 81 in 19-cv-1727-RGA) STIPULATION and Order to Extend Time. Signed by Judge Richard G. Andrews on 4/27/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Apr 24, 2020 | 81 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Order to Extend Time - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 4/27/2020 (nms). |
| Apr 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (79 in 19-cv-1727-RGA; 29 in 19-cv-1674-RGA) STIPULATION TO EXTEND TIME to submit a proposed protective order to May 11, 2020. Signed by Judge Richard G. Andrews on 4/13/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Apr 13, 2020 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Response to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-11) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Apr 10, 2020 | 79 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to May 11, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Apr 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [78] MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Canfield, filed by Hetero USA Inc., Hetero Labs Limited. Signed by Judge Richard G. Andrews on 4/9/2020. (nms) |
| Apr 9, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kenneth S. Canfield for Hetero Labs Limited and Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Apr 8, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pro hac motion filed at D.I. 78 has been removed from the docket per counsel's request as it contained errors. The entry granting the motion has also been removed. Counsel will file a corrected motion. (nms) |
| Apr 8, 2020 | 78 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Canfield - filed by Hetero Labs Limited, Hetero USA Inc.. (Dorsney, Kenneth) |
| Mar 27, 2020 | 77 | Notice (Other) (5) Docket Text: NOTICE of Withdrawal of Counsel Jeffrey J. Lyons, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Lyons, Jeffrey) Modified on 3/27/2020 (nms). |
| Mar 23, 2020 | 76 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's core technical documents filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Mar 20, 2020 | 72 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's Production of Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Alkem Laboratories Limited.(Bilson, David) |
| Mar 20, 2020 | 73 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Core Technical Documents filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Mar 20, 2020 | 74 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.s Responses and Objections to Plaintiffs First Set of Requests for Production filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Mar 20, 2020 | 75 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.s Production of Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Mar 19, 2020 | 71 | Notice Requesting Removal of Co-Counsel (5) Docket Text: NOTICE requesting Clerk to remove Sky C. Adams of Quinn Emanuel Urquhart & Sullivan, LLP as co-counsel. Reason for request: No Longer with Firm. (Tigan, Jeremy) |
| Mar 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (25 in 19-cv-1674-RGA; 70 in 19-cv-1727-RGA) STIPULATION and Order to Extend Time. Signed by Judge Richard G. Andrews on 3/11/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Mar 11, 2020 | 70 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Order to Extend Time - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Lyons, Jeffrey) Modified on 3/12/2020 (nms). |
| Mar 9, 2020 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-7) filed by Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth) |
| Mar 6, 2020 | 67 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Limited's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-9) filed by Alkem Laboratories Limited.(Bilson, David) |
| Mar 6, 2020 | 68 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Response to Plaintiffs' First Set of Requests for Production (Nos. 1-11) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Mar 5, 2020 | 66 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's response to Plaintiffs' First Set of Requests for Production (Nos. 1-12) filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Feb 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (65 in 19-cv-1727-RGA; 24 in 19-cv-1674-RGA) STIPULATION TO EXTEND TIME to submit a proposed protective order to March 11, 2020. Signed by Judge Richard G. Andrews on 2/27/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Feb 26, 2020 | 65 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to March 11, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Feb 17, 2020 | 64 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial ESI Disclosures filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Feb 14, 2020 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Paragraph 3 Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Feb 14, 2020 | 59 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Feb 14, 2020 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery of Defendant Alkem Laboratories Limited filed by Alkem Laboratories Limited.(Bilson, David) |
| Feb 14, 2020 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Feb 14, 2020 | 62 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Paragraph 4(a) Disclosures filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Feb 14, 2020 | 63 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth) |
| Feb 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (57 in 19-cv-1727-RGA; 20 in 19-cv-1674-RGA) STIPULATION TO EXTEND TIME to submit a proposed protective order to February 26, 2020. Signed by Judge Richard G. Andrews on 2/13/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Feb 12, 2020 | 57 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to February 26, 2020 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Feb 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (56 in 19-cv-1727-RGA; 19 in 19-cv-1674-RGA) STIPULATION and Order to Extend Time. Signed by Judge Richard G. Andrews on 2/10/2020. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA(nms) |
| Feb 7, 2020 | 56 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Order for Extension of Time - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 2/10/2020 (nms). |
| Feb 6, 2020 | 55 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things to Defendants filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Feb 4, 2020 | 54 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures filed by Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) |
| Feb 3, 2020 | 53 | Order Setting Teleconference (2) Docket Text: ORDER Setting Teleconference: As a result of the teleconference of 2/3/20, serial teleconferences are scheduled involving plaintiffs counsel and defense counsel with the Court on Monday, February 8, 2021. SEE ORDER FOR DETAILS. Defense counsel for the particular defendant shall initiate the teleconference call. The purpose of these serial teleconferences is to discuss the parties interest in mediation and its timing. If any party wishes to discuss/explore with this Judge mediation at an earlier time frame, it may do so by private, confidential communication with Chambers, including by email to the Court, with a copy to Cathleen Kennedy, Judicial Administrator. Signed by Judge Mary Pat Thynge. (cak) |
| Jan 28, 2020 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Rule 26(a)(1) Initial Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jan 28, 2020 | 49 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures of Defendant Alkem Laboratories Limited Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Alkem Laboratories Limited.(Bilson, David) |
| Jan 28, 2020 | 50 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Tigan, Jeremy) |
| Jan 28, 2020 | 51 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltds Rule 26(a)(1) Initial Disclosures filed by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) |
| Jan 28, 2020 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to Rule 26(a)(1) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) |
| Jan 27, 2020 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's Rule 26(a)(1) Initial Disclosures and Paragraph 3 Disclosures filed by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Jan 13, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Jan 13, 2020 | 45 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/12/2021. Amended Pleadings due by 3/12/2021. Fact Discover completed by 5/14/2021. A Status Conference is set for 1/7/2022, at 09:00 AM in Courtroom 6A. Joint Claim Construction Brief due by 11/23/2020. A Markman Hearing is set for 12/21/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 4/15/2022, at 9:00 AM in Courtroom 6A. A Bench Trial is set for 5/2/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 1/10/2020.. Signed by Judge Richard G. Andrews on 1/10/2020. (nms) |
| Jan 13, 2020 | 46 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 2/3/2020 at 11:30 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 1/13/20. (cak) |
| Jan 10, 2020 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 1/10/2020. Local counsel present for plaintiffs: J. Tigan. Local counsel present for defendants: K. Dorsney, P. Kraman, D. Gattuso, D. Bilson, S. Stamoulis. (Court Reporter Heather Triozzi.) (crb) |
| Jan 8, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [43] MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang, filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 1/8/2020. (nms) |
| Jan 8, 2020 | 44 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding Proposed Scheduling Orders. (Attachments: # (1) Exhibits A-B)(Blumenfeld, Jack) |
| Jan 8, 2020 | 44 | Exhibits A-B (24) |
| Jan 7, 2020 | 43 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Stamoulis, Stamatios) |
| Jan 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [42] MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Sky C. Adams and Allyson E. Parks, filed by Janssen Pharmaceutica NV, Eden Biodesign, LLC., Allergan USA, Inc., Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 1/6/2020. (nms) |
| Jan 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [41] MOTION for Pro Hac Vice Appearance of Attorney Andrea Cheek, filed by Alkem Laboratories Limited. Signed by Judge Richard G. Andrews on 1/3/2020. (nms) |
| Jan 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrea L. Cheek for Alkem Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jan 3, 2020 | 41 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Andrea Cheek - filed by Alkem Laboratories Limited. (Attachments: # (1) Certification)(Bilson, David) Modified on 1/3/2020 (nms). |
| Jan 3, 2020 | 41 | Cheek Pro Hac Certification (1) |
| Jan 3, 2020 | 42 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Sky C. Adams and Allyson E. Parks - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Dec 30, 2019 | 40 | Answer to Counterclaim (9) Docket Text: ANSWER to [33] Answer to Complaint, Counterclaim by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Blumenfeld, Jack) |
| Dec 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [37] MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. Signed by Judge Richard G. Andrews on 12/27/2019. (nms) |
| Dec 23, 2019 | 38 | Answer to Counterclaim (10) Docket Text: ANSWER to [27] Answer to Complaint, Counterclaim, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Blumenfeld, Jack) Modified on 12/27/2019 (nms). |
| Dec 23, 2019 | 39 | Answer to Counterclaim (20) Docket Text: ANSWER to [29] Answer to Complaint, and Counterclaim, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC..(Blumenfeld, Jack) Modified on 12/27/2019 (nms). |
| Dec 22, 2019 | 37 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Attachments: # (1) Exhibit)(Dorsney, Kenneth) |
| Dec 22, 2019 | 37 | Exhibit (1) |
| Dec 18, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Carol M. Pitzel Cruz for Alkem Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Dec 17, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew E. Morrell, Justin E. Culbertson, and William R. Zimmerman for Alkem Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Dec 17, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [36] MOTION for Pro Hac Vice Appearance of Attorney Carol Pitzel Cruz, filed by Alkem Laboratories Limited. Signed by Judge Richard G. Andrews on 12/17/2019. (nms) |
| Dec 17, 2019 | 36 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Carol Pitzel Cruz - filed by Alkem Laboratories Limited. (Attachments: # (1) Certification of Carol Pitzel Cruz)(Bilson, David) |
| Dec 17, 2019 | 36 | Certification of Carol Pitzel Cruz (1) |
| Dec 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [35] MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrew E. Morrell and Justin E. Culbertson, filed by Alkem Laboratories Limited. Signed by Judge Richard G. Andrews on 12/16/2019. (nms) |
| Dec 16, 2019 | 33 | Answer to Complaint (28) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs by Alkem Laboratories Limited.(Phillips, John) Modified on 12/16/2019 (nms). |
| Dec 16, 2019 | 34 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Limited. (Phillips, John) |
| Dec 16, 2019 | 35 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrew E. Morrell and Justin E. Culbertson - filed by Alkem Laboratories Limited. (Attachments: # (1) Certification of William R. Zimmerman, # (2) Certification of Andrew E. Morrell, # (3) Certification of Justin E. Culbertson)(Bilson, David) |
| Dec 16, 2019 | 35 | Certification of William R. Zimmerman (1) |
| Dec 16, 2019 | 35 | Certification of Andrew E. Morrell (1) |
| Dec 16, 2019 | 35 | Certification of Justin E. Culbertson (1) |
| Dec 12, 2019 | 32 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 1/10/2020, at 11:45 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 12/12/2019. (nms) |
| Dec 10, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, Emily L. Savas, and Jonathan B. Turpin for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Dec 6, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [31] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, Emily L. Savas, and Jonathan B. Turpin, filed by Zydus Pharmaceuticals (USA) Inc.. Signed by Judge Richard G. Andrews on 12/6/2019. (nms) |
| Dec 5, 2019 | 31 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, Emily L. Savas, and Jonathan B. Turpin - filed by Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| Dec 2, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Dmitry V. Shelhoff and Edward D. Pergament for Hetero Labs Limited and Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Dec 2, 2019 | 23 | Answer to Complaint (16) Docket Text: ANSWER to [1] Complaint,, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Dec 2, 2019 | 24 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Dec 2, 2019 | 25 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint,, by Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) |
| Dec 2, 2019 | 26 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| Dec 2, 2019 | 27 | Answer to Complaint (26) Docket Text: ANSWER to [1] Complaint, Affirmative Defendants and, COUNTERCLAIMS against All Plaintiffs, by Sun Pharmaceutical Industries Limited.(Gattuso, Dominick) Modified on 12/3/2019 (nms). |
| Dec 2, 2019 | 28 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) |
| Dec 2, 2019 | 29 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against All Plaintiffs, by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) Modified on 12/3/2019 (nms). |
| Dec 2, 2019 | 30 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Stamoulis, Stamatios) |
| Nov 25, 2019 | 21 | Answer to Complaint (14) Docket Text: ANSWER to [1] Complaint,, by Hetero Labs Limited, Hetero USA Inc..(Dorsney, Kenneth) |
| Nov 25, 2019 | 22 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Ltd., Corporate Parent Hetero Drugs Ltd. for Hetero USA Inc. filed by Hetero Labs Limited, Hetero USA Inc.. (Dorsney, Kenneth) |
| Nov 18, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff and Attorney Edward D. Pergament, filed by Hetero USA Inc., Hetero Labs Limited. Signed by Judge Richard G. Andrews on 11/18/2019. (nms) |
| Nov 18, 2019 | 20 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff and Attorney Edward D. Pergament - filed by Hetero Labs Limited, Hetero USA Inc.. (Dorsney, Kenneth) |
| Oct 15, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein for Sun Pharmaceutical Industries Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Oct 15, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Zachary B. Cohen and Jovial Wong for Sun Pharmaceutical Industries Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Oct 9, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong and Zachary B. Cohen, filed by Sun Pharmaceutical Industries Limited. Signed by Judge Richard G. Andrews on 10/9/2019. (nms) |
| Oct 9, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Motion for Pro Hac Vice Appearance (D.I. [17]) is DENIED without prejudice to renew. The motion or certification needs to address the annual filing fee due. Ordered by Judge Richard G. Andrews on 10/9/2019. (nms) |
| Oct 9, 2019 | 19 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong and Zachary B. Cohen - filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) |
| Oct 8, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] STIPULATION TO EXTEND TIME to Respond to Complaint to December 2, 2019 (*Reset Answer Deadlines: Aurobindo Pharma Ltd. answer due 12/2/2019; Aurobindo Pharma USA, Inc. answer due 12/2/2019; Hetero Labs Limited answer due 12/2/2019; Hetero USA Inc. answer due 12/2/2019; MSN Pharmaceuticals, Inc. answer due 12/2/2019; Zydus Pharmaceuticals (USA) Inc. answer due 12/2/2019). Signed by Judge Richard G. Andrews on 10/7/2019. (nms) |
| Oct 8, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to Complaint to December 2, 2019 (*Reset Answer Deadlines: Sun Pharmaceutical Industries Limited answer due 12/2/2019). Signed by Judge Richard G. Andrews on 10/7/2019. (nms) |
| Oct 8, 2019 | 16 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc.: For Aurobindo Pharma Ltd. waiver sent on 9/20/2019, answer due 12/2/2019. (Blumenfeld, Jack) |
| Oct 8, 2019 | 17 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, and Zachary B. Cohen of Winston & Strawn LLP - filed by Sun Pharmaceutical Industries Limited. (Gattuso, Dominick) |
| Oct 7, 2019 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendant Sun Pharmaceutical Industries Limited to Move, Answer or Otherwise Respond to Complaint to December 2, 2019 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Tigan, Jeremy) |
| Oct 4, 2019 | 14 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Respond to Complaint to December 2, 2019 - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Tigan, Jeremy) |
| Sep 30, 2019 | 13 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc.: For MSN Laboratories Private Limited waiver sent on 9/30/2019, answer due 12/2/2019. (Blumenfeld, Jack) |
| Sep 27, 2019 | 12 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc.: For Hetero Labs Limited waiver sent on 9/26/2019, answer due 11/25/2019. (Tigan, Jeremy) |
| Sep 25, 2019 | 11 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Allergan Holdings Unlimited Company, Allergan USA, Inc.: For Alkem Laboratories Limited waiver sent on 9/24/2019, answer due 11/25/2019. (Blumenfeld, Jack) |
| Sep 19, 2019 | 10 | Affidavit of Service (9) Docket Text: AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Zydus Pharmaceuticals (USA) Inc. on September 17, 2019, filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (Blumenfeld, Jack) |
| Sep 18, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Sep 17, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc.. Aurobindo Pharma USA, Inc. served on 9/16/2019, answer due 10/7/2019. (Blumenfeld, Jack) |
| Sep 17, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc.. Sun Pharmaceutical Industries Limited served on 9/16/2019, answer due 10/7/2019. (Blumenfeld, Jack) |
| Sep 17, 2019 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc.. MSN Pharmaceuticals, Inc. served on 9/17/2019, answer due 10/8/2019. (Blumenfeld, Jack) |
| Sep 17, 2019 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc.. Hetero USA Inc. served on 9/17/2019, answer due 10/8/2019. (Blumenfeld, Jack) |
| Sep 16, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Limited on 9/16/2019; Aurobindo Pharma Ltd. on 9/16/2019; Aurobindo Pharma USA, Inc. on 9/16/2019; Hetero Labs Limited on 9/16/2019; Hetero USA Inc. on 9/16/2019; MSN Laboratories Private Limited on 9/16/2019; MSN Pharmaceuticals, Inc. on 9/16/2019; Sun Pharmaceutical Industries Limited on 9/16/2019; Zydus Pharmaceuticals (USA) Inc. on 9/16/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam) |
| Sep 13, 2019 | 1 | Main Document (31) Docket Text: COMPLAINT filed against Alkem Laboratories Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eden Biodesign, LLC., Hetero Labs Limited, Hetero USA Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2730816.) - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(sam) |
| Sep 13, 2019 | 1 | Exhibit A-F (104) |
| Sep 13, 2019 | 1 | Civil Cover Sheet (1) |
| Sep 13, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Sep 13, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or after 07/31/2019. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: On or after 11/27/2022. (sam) |
| Sep 13, 2019 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,691,860; 9,115,091; 9,364,489; 9,675,587; 9,789,125; 10,188,632 (sam) |
| Sep 13, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc for Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (sam) |
| Sep 13, 2019 | 1 | Complaint* (1) |
